<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD001360" GROUP_ID="SCHIZ" ID="088299100919514288" MERGED_FROM="" MODIFIED="2012-01-18 21:12:19 +0100" MODIFIED_BY="Claire Irving" NOTES="&lt;p&gt;Exported from Review Manager 4.2.9&lt;br&gt;Exported from Review Manager 4.3.1&lt;br&gt;Exported from Review Manager 4.2.3&lt;br&gt;Short title (no longer in use): Individual psychodynamic psychotherapy and psychoa&lt;/p&gt;&lt;p&gt;Short title (no longer in use): Individual psychodynamic psychotherapy and psychoa&lt;/p&gt;&lt;p&gt;Short title (no longer in use): Analytic psychotherapy for schizophrenia copy&lt;/p&gt;&lt;p&gt;Ready for submission 23/2/00&lt;/p&gt;&lt;p&gt;Comments by KW 24.04.01:&lt;br&gt;Cover sheet/What's new&lt;br&gt;Please add a sentence or two describing the changes in this update [Handbook: This should describe the major changes to the review since it was last published in the CDSR. For example, you should describe briefly how much new information has been added to the review (e.g. number of studies, participants or extra analyses) and any important changes to the results of the review. ]&lt;/p&gt;&lt;p&gt;Abstract/Search strategy&lt;br&gt;This needs to be updated to reflect the update of the Search strategy section of the text.&lt;/p&gt;&lt;p&gt;References&lt;br&gt;Studies awaiting assessment:&lt;br&gt;Volterra 1996b is identical to one of the references of Volterra 1996 in Excluded studies. Should this reference be deleted from studies awaiting assessment or does the reference describe two different trials (one excluded, one awaiting assessment)???&lt;br&gt;Rogers 1967. Reference not complete. City of publication and publisher are missing. &lt;/p&gt;&lt;p&gt;Other published versions of this review&lt;br&gt;Please enter a citation to the first published version of this review (that is, the version preceeding this update)&lt;/p&gt;" NOTES_MODIFIED="2010-02-16 15:26:41 +0000" NOTES_MODIFIED_BY="[Empty name]" REVIEW_NO="003" REVMAN_SUB_VERSION="5.0.23" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="10.0">
<COVER_SHEET MODIFIED="2012-01-18 21:12:19 +0100" MODIFIED_BY="Claire Irving">
<TITLE>Individual psychodynamic psychotherapy and psychoanalysis for schizophrenia and severe mental illness</TITLE>
<CONTACT MODIFIED="2012-01-18 21:12:19 +0100" MODIFIED_BY="Claire Irving"><PERSON ID="1185154D82E26AA201DC7B3E9165AF7C" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Lena</FIRST_NAME><LAST_NAME>Malmberg</LAST_NAME><EMAIL_1>lena.malmberg@pp.inet.fi</EMAIL_1><ADDRESS><DEPARTMENT>Department of Psychiatry/ Rehabilitation Unit</DEPARTMENT><ORGANISATION>Porvoo Hospital</ORGANISATION><ADDRESS_1>Sairaalantie 2</ADDRESS_1><CITY>Porvoo</CITY><ZIP>FIN-06200</ZIP><COUNTRY CODE="FI">Finland</COUNTRY><PHONE_1>+358 19 54821</PHONE_1><FAX_1>+358 19 666455</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2012-01-18 21:12:19 +0100" MODIFIED_BY="Claire Irving"><PERSON ID="1185154D82E26AA201DC7B3E9165AF7C" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Lena</FIRST_NAME><LAST_NAME>Malmberg</LAST_NAME><EMAIL_1>lena.malmberg@pp.inet.fi</EMAIL_1><ADDRESS><DEPARTMENT>Department of Psychiatry/ Rehabilitation Unit</DEPARTMENT><ORGANISATION>Porvoo Hospital</ORGANISATION><ADDRESS_1>Sairaalantie 2</ADDRESS_1><CITY>Porvoo</CITY><ZIP>FIN-06200</ZIP><COUNTRY CODE="FI">Finland</COUNTRY><PHONE_1>+358 19 54821</PHONE_1><FAX_1>+358 19 666455</FAX_1></ADDRESS></PERSON><PERSON ID="7447" ROLE="AUTHOR"><PREFIX>Mr</PREFIX><FIRST_NAME>Mark</FIRST_NAME><LAST_NAME>Fenton</LAST_NAME><POSITION>Editor</POSITION><EMAIL_1>mark.fenton@nice.org.uk</EMAIL_1><ADDRESS><DEPARTMENT>Database of Uncertainties about the Effects of Treatments (DUETs)</DEPARTMENT><ORGANISATION>National Institute for Health and Clinical Excellence</ORGANISATION><ADDRESS_1>Level 1A, City Tower, Piccadilly Plaza</ADDRESS_1><ADDRESS_2>Middle Way</ADDRESS_2><CITY>Manchester</CITY><ZIP>M1 4BD</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 (0)161 219 3788</PHONE_1><PHONE_2>+44(0)1789 552225</PHONE_2></ADDRESS></PERSON><PERSON ID="BDA7003182E26AA2004D2786DC8C695A" ROLE="AUTHOR"><PREFIX>Mr</PREFIX><FIRST_NAME>John</FIRST_NAME><LAST_NAME>Rathbone</LAST_NAME><POSITION>Systematic Reviewer</POSITION><EMAIL_1>J.Rathbone@sheffield.ac.uk</EMAIL_1><EMAIL_2>John.Rathbone@nottingham.ac.uk</EMAIL_2><ADDRESS><DEPARTMENT>HEDS, ScHARR</DEPARTMENT><ORGANISATION>The University of Sheffield</ORGANISATION><ADDRESS_1>Regent Court</ADDRESS_1><ADDRESS_2>30 Regent Street</ADDRESS_2><CITY>Sheffield</CITY><ZIP>S1 4DA</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 114 222 0890</PHONE_1><PHONE_2>+44 114 272 4095</PHONE_2></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2009-02-26 10:00:32 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Minor update: 12/10/07&lt;/p&gt;&lt;p&gt;New studies found but not yet included or excluded: 22/04/01&lt;/p&gt;&lt;p&gt;New studies found and included or excluded: 16/03/01&lt;/p&gt;&lt;p&gt;Conclusions changed: 22/04/01&lt;/p&gt;&lt;p&gt;Reformatted: 09/10/99&lt;/p&gt;" NOTES_MODIFIED="2009-02-26 10:00:32 +0000" NOTES_MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="2" MONTH="2" YEAR="2009"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="28" MONTH="6" YEAR="2008"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="12" MONTH="5" YEAR="2011"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="1999"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2000"/>
<LAST_CITATION_ISSUE ISSUE="3" YEAR="2001"/>
</DATES>
<WHATS_NEW MODIFIED="2012-01-18 21:12:19 +0100" MODIFIED_BY="Claire Irving" NOTES="&lt;p&gt;May 2001: Additional material from the three years of follow up from the May 1976 study have been included in this update.&lt;/p&gt;" NOTES_MODIFIED="2009-08-06 16:18:57 +0100" NOTES_MODIFIED_BY="[Empty name]"><WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2012-01-18 21:12:19 +0100" MODIFIED_BY="Claire Irving"><DATE DAY="18" MONTH="1" YEAR="2012"/><DESCRIPTION><P>Contact details updated.</P></DESCRIPTION></WHATS_NEW_ENTRY>

</WHATS_NEW>
<HISTORY MODIFIED="2012-01-18 21:12:19 +0100" MODIFIED_BY="Claire Irving"><WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2012-01-18 21:12:19 +0100" MODIFIED_BY="Claire Irving">
<DATE DAY="26" MONTH="2" YEAR="2009"/>
<DESCRIPTION>
<P>One new included study (<LINK REF="STD-Karon-1981" TYPE="STUDY">Karon 1981</LINK>) bringing the total number of included trials to four. We also identified a further report of the <LINK REF="STD-May-1976" TYPE="STUDY">May 1976</LINK> study and were able to extract additional outcome data.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-02-26 10:01:11 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="10" MONTH="12" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS">
<DATE DAY="24" MONTH="5" YEAR="2001"/>
<DESCRIPTION>
<P>Substantive amendment</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Porvoo Hospital</NAME>
<COUNTRY CODE="FI">Finland</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Cochrane Schizophrenia Group</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>Finnish Office for Health Technology Assessment (FinOHTA )</NAME>
<COUNTRY CODE="FI">Finland</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>Finska Läkaresällskapet</NAME>
<COUNTRY CODE="FI">Finland</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2010-02-16 15:26:41 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2009-08-06 16:22:01 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-12-10 16:30:32 +0000" MODIFIED_BY="[Empty name]">Individual psychodynamic psychotherapy and psychoanalysis for schizophrenia and severe mental illness</TITLE>
<SUMMARY_BODY MODIFIED="2009-08-06 16:22:01 +0100" MODIFIED_BY="[Empty name]">
<P>Psychodynamic treatment is an intervention that can be classed as one of the 'talking' therapies. The relationship between the person seeking therapy and the therapist form the main component of the therapy. Its use for people with schizophrenia as a sole treatment, without medication, has not been evaluated very well, apart from four studies in the early 1970s and 1980s. It is clear from the limited studies available that medication is an important part of any treatment for people with psychotic illnesses and should be used in conjunction with any talking treatments.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2010-02-16 14:16:30 +0000" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2010-01-09 17:51:09 +0000" MODIFIED_BY="[Empty name]">
<P>People with schizophrenia and severe mental illness may require considerable support from health care professionals, in most cases over a long period of time. Research on the effects of psychotherapy for schizophrenia has shown mixed results. Although pharmacological interventions remain the treatment of choice, the effects of treatments focusing on psychosocial factors affecting schizophrenia are important.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2010-01-09 17:51:38 +0000" MODIFIED_BY="[Empty name]">
<P>To review the effects of psychodynamic psychotherapy, psychoanalysis, or both, for people with schizophrenia or severe mental illness.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2009-02-03 12:15:33 +0000" MODIFIED_BY="[Empty name]">
<P>For the updated review, we searched the Cochrane Schizophrenia Group Trials Register (June 2008) which is based on regular searches of BIOSIS, CENTRAL, CINAHL, EMBASE, MEDLINE and PsycINFO.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2009-02-03 12:16:27 +0000" MODIFIED_BY="[Empty name]">
<P>We sought all randomised trials of individual psychodynamic psychotherapy or psychoanalysis for people with schizophrenia or severe mental illness.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2009-02-26 10:46:31 +0000" MODIFIED_BY="[Empty name]">
<P>We extracted data independently. For dichotomous data we calculated relative risks (RR) and their 95% confidence intervals (CI) on an intention-to-treat basis using a fixed-effect model. We calculated numbers needed to treat/harm (NNT/NNH) where appropriate. For continuous data, we calculated mean differences (MD) and weighted mean differences (WMD) using a fixed-effect model.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2010-02-16 14:16:30 +0000" MODIFIED_BY="[Empty name]">
<P>We included four randomised trials (total 528 participants, 5 comparisons). All used a psychodynamic approach and reported limited data.</P>
<P>For individual psychodynamic therapy versus medication alone we found significantly more participants in the therapy group were unable to be discharged (n=92, RR 8.35 CI 2.0 to 34.3, NNH 3 CI 2 to 6). We found no significant difference between groups in the number of participants who were re-hospitalised (n=24, RR 0.63 CI 0.3 to 1.4) during long-term analyses. At 12 months, fewer participants in the psychotherapy groups needed additional medications compared with those who did receive medication (n=74, RR 0.64 CI 0.5 to 0.8, NNT 3 CI 3 to 6), and also at three years follow up (n=87, RR 0.85 CI 0.8 to 1.0, NNT 7 CI 5 to 26).<BR/>
</P>
<P>For individual psychodynamic therapy plus medication versus medication alone we found no significant difference in suicide (n=92, RR 0.16 CI 0.01 to 2.9) or suitability for discharge (n=92, RR 1.09 CI 0.2 to 7.4). Also, we found re-hospitalisation rates in long-term analyses were equivocal (n=24, RR 1.00 CI 0.4 to 2.6). For insight-orientated psychodynamic psychotherapy versus reality adaptive psychotherapy we found no significant difference in re-hospitalisation rates (n=164, RR 1.20 CI 0.9 to 1.6), but we found study attrition favoured the insight-orientated psychodynamic psychotherapy group at 12 months (n=164, RR 0.46 CI 0.3 to 0.6, NNT 2 CI 2 to 4). For individual psychodynamic psychotherapy versus group psychotherapy we found no significant difference in global state 'not improved' (n=100, RR 1.27 CI 1.0 to 1.7). For individual psychodynamic therapy plus medication versus individual psychodynamic therapy we found rates of re-hospitalisation during long-term analyses were equivocal (n=24, RR 1.00 CI 0.4 to 2.6). There is no clear evidence of any positive effect of psychodynamic therapy and the possibility of adverse effects seems never to have been considered. We did not identify any trials using a psychoanalytic approach.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>Current data do not support the use of psychodynamic psychotherapy techniques for hospitalised people with schizophrenia. If psychoanalytic therapy is being used for people with schizophrenia there is an urgent need for trials.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2010-02-16 15:26:41 +0000" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2010-01-09 17:55:28 +0000" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2010-01-09 17:53:04 +0000" MODIFIED_BY="[Empty name]">
<P>People with schizophrenia and severe mental illness may require considerable support from health care professionals, in most cases over a long period of time. This support can take many forms including supportive counselling (<LINK REF="REF-McIntosh-2006" TYPE="REFERENCE">McIntosh 2006</LINK>), family interventions (<LINK REF="REF-Pharoah-2006" TYPE="REFERENCE">Pharoah 2006</LINK>), cognitive behavioural approaches (<LINK REF="REF-Jones-2004" TYPE="REFERENCE">Jones 2004</LINK>) and psychodynamic psychotherapy (<LINK REF="REF-Malmberg-1999" TYPE="REFERENCE">Malmberg 1999</LINK>). Research on the effectiveness of psychotherapy for schizophrenia shows mixed results (<LINK REF="REF-Fenton-1995" TYPE="REFERENCE">Fenton 1995</LINK>, <LINK REF="REF-Jones-2004" TYPE="REFERENCE">Jones 2004</LINK>). Some investigators promote the use of an integrated model of rehabilitation for people with schizophrenia, where biological, individual psychological, system-psychological, social and ecological aspects are all taken into account. Treatment of schizophrenia should be based on an understanding of each participant's needs and make further psychological development possible through interactive relations (<LINK REF="REF-Alanen-1997" TYPE="REFERENCE">Alanen 1997</LINK>).</P>
</CONDITION>
<INTERVENTION MODIFIED="2010-01-09 17:54:17 +0000" MODIFIED_BY="[Empty name]">
<P>In recent years, biological theories of schizophrenia have been supported by brain imaging techniques (<LINK REF="REF-Lawrie-1998" TYPE="REFERENCE">Lawrie 1998</LINK>). Medications such as clozapine and new atypical antipsychotic drugs have found their place in reducing psychotic symptoms (<LINK REF="REF-Duggan-2005" TYPE="REFERENCE">Duggan 2005</LINK>, <LINK REF="REF-Essali-2009" TYPE="REFERENCE">Essali 2009</LINK>, <LINK REF="REF-Hunter-2003" TYPE="REFERENCE">Hunter 2003</LINK>). Although antipsychotic drugs remain a treatment of choice for most people with schizophrenia, it is also of interest to look at the effects of treatment methods focusing on psychosocial factors affecting schizophrenia.</P>
</INTERVENTION>
<THEORY MODIFIED="2010-01-09 17:54:40 +0000" MODIFIED_BY="[Empty name]">
<P>Psychoanalysis is not a completely integrated and consistent system of thought - although it is often regarded as such. Psychoanalytic concepts are not all well defined and changes in meaning have occurred as psychoanalysis has changed and theory developed. Psychoanalysis developed to a very great extent in and through the work of Sigmund Freud (1856-1939) but during the course of its evolution Freud himself modified his formulations many times, revising concepts and adding new dimensions to technical procedures (<LINK REF="REF-Sandler-1992" TYPE="REFERENCE">Sandler 1992</LINK>). In the modern era the term psychoanalysis is considered to mean a method of eliciting from patients their past emotional experiences and their role in influencing their current mental life. This is done in order to discover the conflicts and mechanisms by which their pathologic mental state has been preceded and to furnish hints for psychotherapeutic procedures. The method employs free association, recall and interpretation of dreams and interpretation of transference and resistance phenomena.</P>
</THEORY>
<IMPORTANCE MODIFIED="2010-01-09 17:55:28 +0000" MODIFIED_BY="[Empty name]">
<P>The effects of psychoanalytic techniques for people with schizophrenia and similar mental illnesses has been disputed. However, the use of more flexible techniques, including supportive and directive elements, has led to a reappraisal of individual psychodynamic psychotherapy for schizophrenia (<LINK REF="REF-Fenton-1995" TYPE="REFERENCE">Fenton 1995</LINK>). In this review we examine the possible effects of individual psychoanalytic psychotherapy or psychoanalysis in treatment of schizophrenia, alone or as a complement to traditional care.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2010-02-15 15:56:08 +0000" MODIFIED_BY="[Empty name]">
<P>To review the effects of individual psychodynamic psychotherapy or psychoanalysis, with or without standard care, in comparison to standard care (antipsychotic drugs, skills training), other psychosocial interventions or no care.</P>
<P>We also proposed to examine if there are differences in response between:</P>
<P>(i) in- and outpatients;<BR/>(ii) participants living alone or with family;<BR/>(iii) people having their first episode of schizophrenia compared to those whose illness was of longer duration; (iv) strict psychoanalytic techniques and techniques incorporating supportive and directive activity.</P>
</OBJECTIVES>
<METHODS MODIFIED="2010-02-16 14:27:56 +0000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2010-02-16 14:26:09 +0000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2009-08-06 20:28:31 +0100" MODIFIED_BY="[Empty name]">
<P>We included randomised controlled trials. Where a trial is described as 'double-blind' but it is only implied that the study is randomised, we included these trials in a sensitivity analysis. If no substantive difference within primary outcomes (see <LINK TAG="CRIT_OUTCOMES" TYPE="SECTION">Types of outcome measures</LINK>) was found when these 'implied randomisation' studies were added then we included these in the final analysis. If there was a substantive difference, we only used clearly randomised trials and described the results of the sensitivity analysis in the text. We excluded quasi-randomised studies, such as those allocating by using alternate days of the week.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2009-08-06 20:28:48 +0100" MODIFIED_BY="[Empty name]">
<P>We included people with schizophrenia and other types of schizophrenia-like psychoses (e.g. schizophreniform and schizoaffective disorders), irrespective of the diagnostic criteria used. There is no clear evidence that the schizophrenia-like psychoses are caused by fundamentally different disease processes or require different treatment approaches (<LINK REF="REF-Carpenter-1994" TYPE="REFERENCE">Carpenter 1994</LINK>).</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2009-02-26 11:43:37 +0000" MODIFIED_BY="[Empty name]">
<P>As there could be as many definitions of psychodynamic or psychoanalytic therapy as there are studies, we constructed criteria that were felt to be both workable and to capture the elements of good practice in psychodynamic or psychoanalytic therapy. All interventions that did not meet these criteria but were labelled as 'psychodynamic/analytic therapy' or 'psychoanalysis', were included as 'less well defined' therapies. Where appropriate we performed a sensitivity analysis (see Data Collection and analysis - <LINK TAG="SENSITIVITY_ANALYSIS" TYPE="SECTION">Sensitivity analysis</LINK>) in order to investigate if this hierarchy of definition made any difference.</P>
<P>1. Psychodynamic psychotherapy<BR/>We defined psychodynamic psychotherapy as regular individual therapy sessions with a trained psychotherapist, or a therapist under supervision. Therapy sessions were to be based on a psychodynamic or psychoanalytic model. Sessions could rely on a variety of strategies, including explorative insight-oriented, supportive or directive activity, applied flexibly. However, therapists should use a less strict technique than in psychoanalysis. To be considered well-defined psychodynamic psychotherapy, trialists needed to include working with transference.</P>
<P>2. Psychoanalysis<BR/>We defined psychoanalysis as regular individual sessions, planned to last a minimum of 30 minutes, with a trained psychoanalyst three to five times a week. Additionally psychoanalysis should have been planned to continue for at least one year. Analysts were required to adhere to a strict definition of psychoanalytic technique. To be considered well-defined psychoanalysis, trialists needed to report working at the infantile sexual relations level of psychoanalytic theory.</P>
<P>3. Standard care<BR/>The care a person would normally receive had they not been included in the research trial. The category 'standard care' also incorporates 'waiting list control groups' where participants receive drug or other interventions.</P>
<P>4. Other psychosocial therapies<BR/>Additional psychological and/or social interventions, such as non-directive counselling, supportive therapy, cognitive-behavioural therapy and other 'talking therapies'.</P>
<P>5. No care<BR/>This group included people randomised to no treatment or to a waiting list without receiving any care.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2010-02-16 14:26:09 +0000" MODIFIED_BY="[Empty name]">
<P>Where possible, we grouped outcomes into the following time periods: 1 to 6 months (short term), 7 to 12 months (medium term), and more than 12 months (long term).</P>
<CRIT_OUTCOMES_PRIMARY MODIFIED="2009-02-26 11:50:07 +0000" MODIFIED_BY="[Empty name]">
<P>1. No clinically important response as defined by the individual studies (e.g. global impression less than much improved or less than 50% reduction on a rating scale).</P>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2010-02-16 14:26:09 +0000" MODIFIED_BY="[Empty name]">
<P>1. Leaving the studies early (any reason, adverse effects, inefficacy of treatment)<BR/>
</P>
<P>2. Global state<BR/>2.1 No clinically important change in global state (as defined by individual studies)<BR/>2.2 Relapse (as defined by the individual studies)</P>
<P>3. Mental state (with particular reference to the positive and negative symptoms of schizophrenia)<BR/>3.1 No clinically important change in general mental state score<BR/>3.2 Average endpoint general mental state score<BR/>3.3 Average change in general mental state score<BR/>3.4 No clinically important change in specific symptoms (positive symptoms of schizophrenia, negative symptoms of schizophrenia)<BR/>3.5 Average endpoint specific symptom score<BR/>3.6 Average change in specific symptom score</P>
<P>4. General functioning<BR/>4.1 No clinically important change in general functioning<BR/>4.2 Average endpoint general functioning score<BR/>4.3 Average change in general functioning score</P>
<P>5. Quality of life/satisfaction with treatment<BR/>5.1 No clinically important change in general quality of life<BR/>5.2 Average endpoint general quality of life score<BR/>5.3 Average change in general quality of life score</P>
<P>6. Cognitive functioning<BR/>6.1 No clinically important change in overall cognitive functioning<BR/>6.2 Average endpoint of overall cognitive functioning score<BR/>6.3 Average change of overall cognitive functioning score</P>
<P>7. Service use<BR/>7.1 Number of participants hospitalised</P>
<P>8. Adverse effects<BR/>8.1 Number of participants with at least one adverse effect<BR/>8.2 Clinically important specific adverse effects (cardiac effects, death, movement disorders, prolactin increase and associated effects, weight gain, effects on white blood cell count)<BR/>8.3 Average endpoint in specific adverse effects<BR/>8.4 Average change in specific adverse effects</P>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2010-02-03 18:48:58 +0000" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2010-02-03 18:48:58 +0000" MODIFIED_BY="[Empty name]">
<P>1. Update search<BR/>We searched the Cochrane Schizophrenia Group Trials Register (June 2008) using the phrase:</P>
<P>(psychoanaly* or psychodynamic* or insight?orient* or * EIO* or analytic* or dynamic*) in title, abstract and index fields in REFERENCE) OR (psychoanalys* or psychodynam* or insight?orient*  or reality?adap* in interventions field in STUDY)]</P>
<P>This register is compiled by systematic searches of major databases, hand searches and conference proceedings (see <A HREF="http://mrw.interscience.wiley.com/cochrane/cochrane_clsysrev_crglist_fs.html">Group Module</A>).</P>
<P>2. Previous electronic searches<BR/>Please see <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.<BR/>
</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2009-07-24 11:47:45 +0100" MODIFIED_BY="[Empty name]">
<P>1. Reference searching<BR/>We inspected references of all identified studies for more trials.</P>
<P>2. Personal contact<BR/>We contacted the first author of each included study for missing information.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2010-02-16 14:27:56 +0000" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2009-08-06 20:37:20 +0100" MODIFIED_BY="[Empty name]">
<P>Two reviewers independently inspected all study citations identified by the searches and full reports of the studies of agreed relevance were obtained. Where disputes arose, we acquired the full report for more detailed scrutiny. These articles were then inspected, independently, by two reviewers to assess their relevance to this review. Again, where disagreement occurred attempts were made to resolve this through discussion; if doubt still remained we added these trials to the list of those awaiting assessment pending acquisition of further information.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2009-08-13 14:58:15 +0100" MODIFIED_BY="[Empty name]">
<P>1. Data Extraction<BR/>We independently extracted data. Where disagreement occurred attempts were made to resolve this by discussion, where doubt still remained we sought further information from the study authors to resolve the dilemma, and added the trial to the list of those awaiting assessment.</P>
<P>2. Management<BR/>We extracted the data onto standard, simple forms. Where possible we entered data into RevMan in such a way that the area to the left of the line of no effect indicated a favourable outcome for the treatment group. Where this was not possible, for example for scales that calculate higher scores = improvement, graphs in RevMan analyses were labelled accordingly so that the direction of effects were clear.</P>
<P>3. Scale-derived data<BR/>3.1 Valid scales<BR/>A wide range of instruments are available to measure outcomes in mental health studies. These instruments vary in quality and many are not validated or are even ad hoc. It is accepted generally that measuring instruments should have the properties of reliability (the extent to which a test effectively measures anything at all) and validity (the extent to which a test measures that which it is supposed to measure) (<LINK REF="REF-Rust-1989" TYPE="REFERENCE">Rust 1989</LINK>). Unpublished scales are known to be subject to bias in trials of treatments for schizophrenia (<LINK REF="REF-Marshall-2000" TYPE="REFERENCE">Marshall 2000</LINK>). Therefore continuous data from rating scales were included only if the measuring instrument had been described in a peer reviewed journal. In addition, the following minimum standards for instruments were set: the instrument should either be (a) a self-report or (b) completed by an independent rater or relative (not the therapist) and (c) the instrument should be a global assessment of an area of functioning.</P>
<P>3.2 Binary outcomes from scale data<BR/>Where possible, efforts were made to convert outcome measures to binary data. This can be done by identifying cut-off points on rating scales and dividing participants accordingly into 'clinically improved' or 'not clinically improved'. It was generally assumed that if there had been a 50% reduction in a scale-derived score such as the Brief Psychiatric Rating Scale (BPRS, <LINK REF="REF-Overall-1962" TYPE="REFERENCE">Overall 1962</LINK>) or the Positive and Negative Syndrome Scale (PANSS, <LINK REF="REF-Kay-1986" TYPE="REFERENCE">Kay 1986</LINK>), this could be considered as a clinically significant response (<LINK REF="REF-Leucht-2005a" TYPE="REFERENCE">Leucht 2005a</LINK>, <LINK REF="REF-Leucht-2005b" TYPE="REFERENCE">Leucht 2005b</LINK>). It was recognised that for many people, especially those with chronic or severe illness, a less rigorous definition of important improvement (e.g. 25% on the BPRS) would be equally valid. If individual patient data were available, the 50% cut-off was used for the definition in the case of non-chronically ill people and 25% for those with chronic illness. If data based on these thresholds were not available, we used the primary cut-off presented by the original authors.<BR/>
</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2010-02-16 14:27:07 +0000" MODIFIED_BY="[Empty name]">
<P>We assessed the risk of bias by using the criteria described in the Cochrane Handbook for Systematic Reviews of Interventions (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>) to assess trial quality. The assessment considers how the sequence was generated, how allocation was concealed, the integrity of blinding at outcome, the completeness of outcome data, selective reporting and other biases. We would not have included studies where sequence generation was at high risk of bias or where allocation was clearly not concealed.</P>
<P>The categories are defined below:<BR/>YES - low risk of bias<BR/>NO - high risk of bias<BR/>UNCLEAR - uncertain risk of bias<BR/>
</P>
<P>If disputes arose as to which category a trial has to be allocated, again, resolution was made by discussion, after working with a third reviewer.</P>
<P>Earlier versions of this review used a different means of categorising risk of bias (see <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>).</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2009-08-06 20:44:11 +0100" MODIFIED_BY="[Empty name]">
<P>1. Binary data<BR/>We calculated the relative risk (RR) and its 95% confidence interval (CI) based on the fixed-effect model. Relative risk is more intuitive (<LINK REF="REF-Boissel-1999" TYPE="REFERENCE">Boissel 1999</LINK>) than odds ratios and odds ratios tend to be interpreted as RR by clinicians (<LINK REF="REF-Deeks-2000" TYPE="REFERENCE">Deeks 2000</LINK>). This misinterpretation then leads to an overestimate of the impression of the effect. When the overall results were significant we calculated the number needed to treat (NNT) and the number needed to harm (NNH) using Visual Rx (<A HREF="http://www.nntonline.net/">http://www.nntonline.net/</A>). Where people were lost to follow up at the end of the study, we assumed that they had had a poor outcome and once they were randomised they were included in the analysis (intention-to-treat (ITT) analysis).</P>
<P>2. Continuous data<BR/>2.1 Normal distribution<BR/>Continuous data on outcomes in trials relevant to mental health issues are often not normally distributed. To avoid the pitfall of applying parametric tests to non-parametric data we applied the following standards to continuous final value endpoint data before inclusion: (a) standard deviations and means were reported in the paper or were obtainable from the authors; (b) when a scale started from zero, the standard deviation, when multiplied by two, should be less than the mean (otherwise the mean is unlikely to be an appropriate measure of the centre of the distribution - <LINK REF="REF-Altman-1996" TYPE="REFERENCE">Altman 1996</LINK>); In cases with data that are greater than the mean they were entered into 'Other data' table as skewed data. If a scale starts from a positive value (such as PANSS, which can have values from 30 to 210) the calculation described above in (b) should be modified to take the scale starting point into account. In these cases skewness is present if 2SD&gt;(S-Smin), where S is the mean score and Smin is the minimum score.</P>
<P>Skewed endpoint data from studies with less the 200 participants were not shown graphically, but were added to 'Other data' tables and briefly commented on in the text. However, skewed endpoint data from larger studies (&#8805;200 participants) pose less of a problem and we entered the data for analysis.</P>
<P>For change data (mean change from baseline on a rating scale) it is impossible to tell whether data are non-normally distributed (skewed) or not, unless individual patient data are available. After consulting the ALLSTAT electronic statistics mailing list, we entered change data in RevMan analyses and reported the finding in the text to summarise available information. In doing this, we assumed either that data were not skewed or that the analysis could cope with the unknown degree of skew.</P>
<P>2.2 Data synthesis<BR/>For continuous outcomes we estimated a weighted mean difference (MD) between groups based on a fixed-effect model.</P>
<P>2.3 Final endpoint value versus change data<BR/>Where both final endpoint data and change data were available for the same outcome category, only final endpoint data were presented. We acknowledge that by doing this much of the published change data may be excluded, but argue that endpoint data is more clinically relevant and that if change data were to be presented along with endpoint data, it would be given undeserved equal prominence.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2009-08-06 20:46:21 +0100" MODIFIED_BY="[Empty name]">
<P>1. Cluster trials<BR/>Studies increasingly employ cluster randomisation (such as randomisation by clinician or practice) but analysis and pooling of clustered data poses problems. Firstly, authors often fail to account for intraclass correlation in clustered studies, leading to a 'unit of analysis' error (<LINK REF="REF-Divine-1992" TYPE="REFERENCE">Divine 1992</LINK>) whereby p values are spuriously low, confidence intervals unduly narrow and statistical significance overestimated. This can cause Type I errors (<LINK REF="REF-Bland-1997" TYPE="REFERENCE">Bland 1997</LINK>, <LINK REF="REF-Gulliford-1999" TYPE="REFERENCE">Gulliford 1999</LINK>).</P>
<P>Where clustering had not been accounted for in primary studies, we presented the data in a table with a (*) symbol to indicate the presence of a probable unit of analysis error. In subsequent versions of this review we will seek to contact first authors of studies to obtain intraclass correlation coefficients of their clustered data and to adjust for this using accepted methods (<LINK REF="REF-Gulliford-1999" TYPE="REFERENCE">Gulliford 1999</LINK>). Where clustering has been incorporated into the analysis of primary studies, we will also present these data as if from a non-cluster randomised study, but adjusted for the clustering effect.</P>
<P>We have sought statistical advice and have been advised that the binary data as presented in a report should be divided by a design effect. This is calculated using the mean number of participants per cluster (m) and the intraclass correlation coefficient (ICC) [Design effect=1+(m-1)*ICC] (<LINK REF="REF-Donner-2002" TYPE="REFERENCE">Donner 2002</LINK>). If the ICC is not reported we assumed it to be 0.1 (<LINK REF="REF-Ukoumunne-1999" TYPE="REFERENCE">Ukoumunne 1999</LINK>).</P>
<P>If cluster studies had been appropriately analysed taking into account intraclass correlation coefficients and relevant data documented in the report, we synthesised these with other studies using the generic inverse variance technique.</P>
<P>2. Cross-over trials<BR/>A major concern of cross-over trials is the carry-over effect. It occurs if an effect (e.g. pharmacological, physiological or psychological) of the treatment in the first phase is carried over to the second phase. As a consequence on entry to the second phase the participants can differ systematically from their initial state despite a wash-out phase. For the same reason cross-over trials are not appropriate if the condition of interest is unstable (<LINK REF="REF-Elbourne-2002" TYPE="REFERENCE">Elbourne 2002</LINK>). As both effects are very likely in schizophrenia, we will only use data of the first phase of cross-over studies.</P>
<P>3. Studies with multiple treatment groups<BR/>Where a study involved more than two treatment arms, if relevant, the additional treatment arms were presented in comparisons. Where the additional treatment arms were not relevant, these data were not reproduced.<BR/>
</P>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2009-08-10 09:36:26 +0100" MODIFIED_BY="[Empty name]">
<P>At some degree of loss to follow-up data must lose credibility (<LINK REF="REF-Xia-2007" TYPE="REFERENCE">Xia 2007</LINK>). We excluded data from studies where more than 50% of participants in any group were lost to follow up (this did not include the outcome of 'leaving the study early'). In studies with less than 50% dropout rate, people leaving early were considered to have had the negative outcome, except for the event of death. Where high attrition occurred in primary outcomes we analysed the impact of including studies with high attrition rates (25-50%) in a sensitivity analysis. If inclusion of data from this latter group resulted in a substantive change in the estimate of effect, we did not add their data to trials with less attrition, but presented them separately.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2009-07-29 10:01:20 +0100" MODIFIED_BY="[Empty name]">
<P>1. Clinical heterogeneity<BR/>We considered all included studies without any comparison to judge clinical heterogeneity.</P>
<P>2. Statistical<BR/>2.1 Visual inspection<BR/>We visually inspected graphs to investigate the possibility of statistical heterogeneity.</P>
<P>2.2 Employing the I-squared statistic<BR/>This provided an estimate of the percentage of inconsistency thought to be due to chance. I-squared estimate greater than or equal to 50% was interpreted as evidence of high levels of heterogeneity (<LINK REF="REF-Higgins-2003" TYPE="REFERENCE">Higgins 2003</LINK>).<BR/>
</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2009-08-06 20:47:56 +0100" MODIFIED_BY="[Empty name]">
<P>Reporting biases arise when the dissemination of research findings is influenced by the nature and direction of results. These are described in section 10.1 of the Cochrane Handbook for Systematic Reviews of Interventions (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>). We are aware that funnel plots may be useful in investigating reporting biases but are of limited power to detect small-study effects (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>). Funnel plots were not used for outcomes involving 10 or fewer studies, or where all studies were of similar sizes. In other cases, where funnel plots were possible, we sought statistical advice in their interpretation.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2010-02-16 14:27:56 +0000" MODIFIED_BY="[Empty name]">
<P>Where possible we used a random-effect model for analyses. We understand that there is no closed argument for preference for use of fixed or random-effects models. The random-effects method incorporates an assumption that the different studies are estimating different, yet related, intervention effects. This does seem true to us, however, random-effects does put added weight onto the smaller studies - those trials that are most vulnerable to bias.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2009-07-29 10:37:18 +0100" MODIFIED_BY="[Empty name]">
<P>When heterogeneous results were found, we investigated the reasons for this. Where heterogeneous data substantially altered the results and the reasons for the heterogeneity were identified, these studies were not summated in the meta-analysis, but presented separately and discussed in the text.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2009-08-06 20:49:21 +0100" MODIFIED_BY="[Empty name]">
<P>The effects of including studies with high attrition rates would be analysed in a sensitivity analysis. Where data is available, sensitivity analyses will be performed to investigate whether there were differences:</P>
<P>1. in response between in- and outpatients;<BR/>2. between participants living alone or with family;<BR/>3. in people having their first episode of schizophrenia compared to those whose illness was of longer duration;<BR/>4. between strict psychoanalytic techniques and techniques incorporating supportive and directive activity; and<BR/>5. between studies of well-defined psychotherapy (as defined by the reviewers) and studies of less well defined psychotherapy (as defined by the reviewers).</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2010-02-16 14:53:58 +0000" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2010-02-16 14:43:07 +0000" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2009-08-07 11:13:24 +0100" MODIFIED_BY="[Empty name]">
<P>The update search (June 2008) of the Cochrane Schizophrenia Groups Register produced 32 citations relating to 25 trials. No studies were selected for further inspection. In an earlier update search of the Cochrane Schizophrenia Group Trials Register (December 2006) we found 350 new references from 154 studies identified since the last search (August 2000). From these, 12 citations were selected for further inspection. Three were further reports of studies included in the review which did not contain additional data. Seven were excluded because they were not psychodynamic interventions. We included one newly identified study (<LINK REF="STD-Karon-1981" TYPE="STUDY">Karon 1981</LINK>) bringing the total number of included trials to four. We also identified a further report of <LINK REF="STD-May-1976" TYPE="STUDY">May 1976</LINK> and were able to extract some additional outcome data.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2010-02-16 14:43:07 +0000" MODIFIED_BY="[Empty name]">
<P>1. Design<BR/>Only four studies reported data in a way that could be extracted for inclusion (<LINK REF="STD-O_x0027_Brien-1972" TYPE="STUDY">O'Brien 1972</LINK>, <LINK REF="STD-May-1976" TYPE="STUDY">May 1976</LINK>, <LINK REF="STD-Karon-1981" TYPE="STUDY">Karon 1981</LINK> and <LINK REF="STD-Gunderson-1984" TYPE="STUDY">Gunderson 1984</LINK>). All included trials were randomised and none double-blind. Grants from the US National Institute of Mental Health supported all of the included studies.</P>
<P>2. Length of trials<BR/>
<LINK REF="STD-Gunderson-1984" TYPE="STUDY">Gunderson 1984</LINK> followed participants for two years. <LINK REF="STD-Karon-1981" TYPE="STUDY">Karon 1981</LINK> lasted for 20 months and <LINK REF="STD-O_x0027_Brien-1972" TYPE="STUDY">O'Brien 1972</LINK> continued intervention for 20 months. In <LINK REF="STD-May-1976" TYPE="STUDY">May 1976</LINK> participants were initially treated for 6-12 months and when treatment stopped, participants were followed for up to five years, although complete data are only available up to three years.</P>
<P>3. Participants<BR/>One study used an operational diagnosis of schizophrenia (<LINK REF="STD-Gunderson-1984" TYPE="STUDY">Gunderson 1984</LINK>). This study spanned the changeover from DSM (Diagnostic Statistical Manual) version II to III. None of the other studies appeared to use operational diagnoses of schizophrenia. <LINK REF="STD-May-1976" TYPE="STUDY">May 1976</LINK> excluded those who were 'obviously not going to be discharged within two years and those whose illness went into remission during the assessment period'. <LINK REF="STD-O_x0027_Brien-1972" TYPE="STUDY">O'Brien 1972</LINK> included those whose diagnosis was schizophrenia and whose case notes contained 'clear evidence of a psychotic episode'. <LINK REF="STD-Karon-1981" TYPE="STUDY">Karon 1981</LINK> aimed to include people who were acutely ill, but clearly identified as having schizophrenia.</P>
<P>
<LINK REF="STD-Gunderson-1984" TYPE="STUDY">Gunderson 1984</LINK> and <LINK REF="STD-Karon-1981" TYPE="STUDY">Karon 1981</LINK> did not report the gender of the included participants. Both <LINK REF="STD-May-1976" TYPE="STUDY">May 1976</LINK> and <LINK REF="STD-O_x0027_Brien-1972" TYPE="STUDY">O'Brien 1972</LINK> included men and women. The participants age ranged from 18-35 years in the <LINK REF="STD-Gunderson-1984" TYPE="STUDY">Gunderson 1984</LINK> study and <LINK REF="STD-O_x0027_Brien-1972" TYPE="STUDY">O'Brien 1972</LINK> reported a mean age of 36 to 37 years. Participants ages were not reported by <LINK REF="STD-Karon-1981" TYPE="STUDY">Karon 1981</LINK> or <LINK REF="STD-May-1976" TYPE="STUDY">May 1976</LINK>. Participants in the <LINK REF="STD-O_x0027_Brien-1972" TYPE="STUDY">O'Brien 1972</LINK> study had a mean number of admissions of about three. <LINK REF="STD-May-1976" TYPE="STUDY">May 1976</LINK> only included people having their first admission. <LINK REF="STD-Gunderson-1984" TYPE="STUDY">Gunderson 1984</LINK> selected those who had minimal prior treatment, no history of alcohol dependence or drug abuse, and had been able to function outside of hospital in some major role without medication for four consecutive months in the previous two years, which suggests that participants were not similar to those seen in clinical practice. <LINK REF="STD-Karon-1981" TYPE="STUDY">Karon 1981</LINK> specified acute first episode participants, but at least one third were discovered to have had previous hospital admissions.</P>
<P>4. Setting<BR/>Most participants in the included studies were initially in hospital, with all eventually proceeding to outpatient status.</P>
<P>5. Study size<BR/>
<LINK REF="STD-Gunderson-1984" TYPE="STUDY">Gunderson 1984</LINK> initially randomised 164 people and 69 left the study early (before six months); only details of the 95 who stayed in therapy beyond six months are reported. <LINK REF="STD-May-1976" TYPE="STUDY">May 1976</LINK> randomised 228 people, <LINK REF="STD-O_x0027_Brien-1972" TYPE="STUDY">O'Brien 1972</LINK> 100, and <LINK REF="STD-Karon-1981" TYPE="STUDY">Karon 1981</LINK> 36.</P>
<P>6. Interventions<BR/>We are unable to make definitive comments on whether the initial definitions of psychoanalytic or psychodynamic treatment in this review are the same as those employed in the included studies. Information is poor within the studies, especially relating to frequency of administration and orientation of the therapists. In effect, inclusion of <LINK REF="STD-O_x0027_Brien-1972" TYPE="STUDY">O'Brien 1972</LINK> and <LINK REF="STD-May-1976" TYPE="STUDY">May 1976</LINK> resulted from supposition that lengthy psychotherapy, undertaken in the 1970s by people who did not explicitly mention that the intervention was psychoanalytic in nature, would mean that it is a psychodynamic therapy. <LINK REF="STD-May-1976" TYPE="STUDY">May 1976</LINK> presented no descriptions of the orientation of the therapy or therapists. He mentioned the supervision of the treatment. "Each patient's treatment was supervised by an experienced consultant who believed in the efficacy of the particular treatment that he supervised" (<LINK REF="STD-May-1976" TYPE="STUDY">May 1976</LINK>). <LINK REF="STD-O_x0027_Brien-1972" TYPE="STUDY">O'Brien 1972</LINK> also gave no mention of the orientation of the therapists or therapy. "The purpose of our study was to determine the relative effectiveness of group and individual therapy for schizophrenic aftercare patients" (<LINK REF="STD-O_x0027_Brien-1972" TYPE="STUDY">O'Brien 1972</LINK>). Therapists were said to be supervised if they were students (normally medical), but other therapists were not said to be in supervision. The treatment duration had not been reported, but follow up was intended to be for 24 months. No explicit definition of the therapy is mentioned for <LINK REF="STD-Gunderson-1984" TYPE="STUDY">Gunderson 1984</LINK>, but several references are made to Stanton's psychodynamic/psychoanalytic orientation (one of the main authors). "Stanton in designing this project, made use of the technique of the randomised trial to 'test' his cherished beliefs that individual psychodynamically-orientated psychotherapy would have a therapeutic effect on the cognitive functioning, psychopathology and social functioning of schizophrenic patients" (<LINK REF="STD-Klerman-1984" TYPE="STUDY">Klerman 1984</LINK>). In <LINK REF="STD-Karon-1981" TYPE="STUDY">Karon 1981</LINK> three interventions were used. Group 'A', the psychodynamic group without medication, received five sessions per week for the first two to eight weeks until discharge. Thereafter, psychotherapy sessions were provided once per week until the end of the study. Group 'B', the psychodynamic group with medication, received an 'ego-analytic' psychotherapy approach three times per week for at least 20 sessions which then reduced to one session per week. These participants also received adjunctive phenothiazines. Group 'C' received standard care.</P>
<P>7. Outcomes<BR/>7.1 Improvement<BR/>Definition of improvement varied but seemed to be based on more pragmatic - and more useful - outcomes than have been measured in many other systematic reviews of schizophrenia treatments. Days in hospital, ability to be discharged, role functioning and self-support were the primary outcomes.</P>
<P>7.2 Missing outcomes<BR/>Data on adverse effects were not collected and do not seem to have been considered by any of the trialists. Data on use of medication seemed to have been collected in the studies, but were not reported, except when it was the comparator treatment. <LINK REF="STD-May-1976" TYPE="STUDY">May 1976</LINK> gives long term follow-up data for those who received additional medication or eventually received medication. No trial reported on economic outcomes. The scales used for measuring some of the outcomes do not seem to be global measures. Many trials presented findings in graphs or by p-values alone. Graphical presentation made it impossible to acquire data for synthesis; p-values were commonly used as a measure of association between intervention and outcomes instead of showing the strength of the association. Many did not provide standard deviations of means or did not give any information.</P>
<P>7.3 Continuous data<BR/>On the whole, no scale-derived continuous data were provided in initial reports of any of the studies. <LINK REF="STD-May-1976" TYPE="STUDY">May 1976</LINK> does give a continuous result from the Menninger Health Sickness Scale, which is included in this review. Other continuous outcomes were measured, such as days in hospital, but the standard deviation is not reported. Reasons for exclusion of data from other instruments are given under 'Outcomes' in the '<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>' tables.</P>
<P>7.4 Outcome scales<BR/>7.4.1 Menninger Health Sickness Rating Scale - HSRS (<LINK REF="REF-Luborsky-1962" TYPE="REFERENCE">Luborsky 1962</LINK>)<BR/>Scoring 0 to 100, the Health Sickness Rating Scale was developed to provide a simple survey instrument to record shorthand judgements of a patient's status, recording changes over time and allowing comparisons between patients. It provides a global rating with seven criteria and with other personality qualities. <LINK REF="STD-May-1976" TYPE="STUDY">May 1976</LINK> reported usable data from this scale.</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2009-11-30 10:44:28 +0000" MODIFIED_BY="[Empty name]">
<P>Fifty-seven studies are excluded; the majority because they are reviews of either the included studies or of the literature. Many were excluded because they were studies of other types of interventions (short versus long hospitalisation, family management, what seems to be cognitive behavioural therapy, cognitive behavioural therapy and attitudinal changes); two were comparisons of the effects of drugs on ego function or symbol formation; one seemed to be psychoanalysis, but used a case-control study with a heterogeneous group of participants, with no data being available just for those with schizophrenia; and another used a retrospective design (<LINK REF="STD-Lindberg-1981" TYPE="STUDY">Lindberg 1981</LINK>). Three did not include participants with schizophrenia (<LINK REF="STD-Guthrie-1997" TYPE="STUDY">Guthrie 1997</LINK>, <LINK REF="STD-Chiesa-1999" TYPE="STUDY">Chiesa 1999</LINK>, <LINK REF="STD-Schachter-2001" TYPE="STUDY">Schachter 2001</LINK>). Three studies were excluded because they had no available data (<LINK REF="STD-Karon-1969" TYPE="STUDY">Karon 1969</LINK>, <LINK REF="STD-Sjostrom-1990" TYPE="STUDY">Sjostrom 1990</LINK>, <LINK REF="STD-Volterra-1996" TYPE="STUDY">Volterra 1996</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Awaiting assessment</HEADING>
<P>We are currently seeking further information from one potentially randomised study (<LINK REF="STD-Wilner-1985" TYPE="STUDY">Wilner 1985</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Ongoing studies</HEADING>
<P>We are not aware of any ongoing studies.</P>
</SUBSECTION>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2010-02-16 14:47:40 +0000" MODIFIED_BY="[Empty name]">
<P>The barely adequate reporting of randomisation and lack of double-blindness for these outcomes would suggest that all estimates of effect of the experimental intervention are prone to exaggeration (<LINK REF="REF-Moher-1998" TYPE="REFERENCE">Moher 1998</LINK>). Judgement of risks are illustrated in <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK>.</P>
<ALLOCATION MODIFIED="2009-08-10 10:14:46 +0100" MODIFIED_BY="[Empty name]">
<P>All four trials were stated to be randomised, but none described how randomisation had been achieved nor who performed the procedure. The reader is not assured that biases were not introduced. Studies have shown that poor reporting of randomisation increases the odds of presenting 'significant' outcomes (<LINK REF="REF-Chalmers-1983" TYPE="REFERENCE">Chalmers 1983</LINK>, <LINK REF="REF-Schulz-1995" TYPE="REFERENCE">Schulz 1995</LINK>).</P>
</ALLOCATION>
<BLINDING MODIFIED="2010-01-09 18:07:38 +0000" MODIFIED_BY="[Empty name]">
<P>None of the studies attempted to blind participants or investigators to the type of treatment intervention. <LINK REF="STD-Gunderson-1984" TYPE="STUDY">Gunderson 1984</LINK> and <LINK REF="STD-May-1976" TYPE="STUDY">May 1976</LINK> used independent assessors, whereas in <LINK REF="STD-O_x0027_Brien-1972" TYPE="STUDY">O'Brien 1972</LINK> the study staff rated the participants of the other therapists, with no one eligible to rate their own work or the participants they were working with. <LINK REF="STD-Karon-1981" TYPE="STUDY">Karon 1981</LINK> reported that the assessors were blinded to treatment groups, but did not describe whether this had been implemented successfully. No study clearly described adequate precautions for blinding of assessment. It is important that those extracting data from studies are assured that trialists minimised the introduction of bias when assessing the impact of interventions.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2010-01-09 18:09:40 +0000" MODIFIED_BY="[Empty name]">
<P>
<LINK REF="STD-Gunderson-1984" TYPE="STUDY">Gunderson 1984</LINK> only followed up those who completed six months of treatment giving a rate of attrition of 42% from the start. At 12 months, 56% had left and at 24 months, 71%. Participants who were discharged or dropped out after six months, seem, nevertheless, to have been followed up - a practice that is rare in schizophrenia research - and very informative. In <LINK REF="STD-May-1976" TYPE="STUDY">May 1976</LINK> most participants remained in the study with over 90% completion for both groups. This study is also remarkable as it managed to follow up participants for up to five years. In <LINK REF="STD-O_x0027_Brien-1972" TYPE="STUDY">O'Brien 1972</LINK> at 12 months, the percentage who left the study early is 58% in the individual analysis group and 38% in the group psychotherapy group, giving an overall rate at 12 months of 48%. At 20 months, it is 90% and 82% respectively, with a pooled rate of 86%. This includes those who were eligible for discharge. Again, the authors were able to follow people up. In <LINK REF="STD-Karon-1981" TYPE="STUDY">Karon 1981</LINK> a total of 36 participants were randomised. Subsequently, three participants were excluded from the study but it is not clear from which of the three intervention groups this occurred.</P>
<P>No study stated that they analysed their data on an intention-to-treat basis. Once people leave, unless trialists continue to follow and collect data, assumptions have to be made about outcome. As many people left these studies early, the results do incorporate considerable assumptions. In this review those leaving the studies early were classified as a 'bad outcome' and analysed accordingly (except for the outcome of death). Whatever the management of lost data, interpretation of results with large degrees of attrition must be undertaken with caution. Where greater than 50% of those randomised were lost to follow up outcomes are marked with an asterisk (*) in order to draw the attention of the reader to the 'prone to bias' footnote.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2010-02-16 14:47:40 +0000" MODIFIED_BY="[Empty name]">
<P>Much of the available data were rendered unusable due to missing standard deviations or a complete absence of data (BPRS) on mental states scores. It is unclear whether this was due to the data being selectively reported or simply as a result of poor reporting.</P>
</SELECTIVE_REPORTING>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2010-02-16 14:53:58 +0000" MODIFIED_BY="[Empty name]">
<P>Only one study is available for inclusion in each comparison.</P>
<P>1. COMPARISON 1. INDIVIDUAL PSYCHODYNAMIC PSYCHOTHERAPY versus MEDICATION<BR/>
<LINK REF="STD-May-1976" TYPE="STUDY">May 1976</LINK> is included in this comparison (<LINK REF="SOF-01" TYPE="SOF">Summary of findings table 1</LINK>).</P>
<P>1.1 Committed suicide by three years<BR/>We found no significance difference for the outcome of committing suicide at three years. Three people in the group which received medication and one in the group treated solely with psychotherapy committed suicide (n=92, RR 0.52 CI 0.1 to 5.6, <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>).</P>
<P>1.2 Global impression: not able to be discharged<BR/>We found more participants in the psychotherapy group were not eligible for discharge compared with the participants given only medication (1 RCT, n=92, RR 8.35 CI 2.0 to 34.3, NNH 3 CI 2 to 6, <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>).</P>
<P>1.3 Global impression: given additional medication or received medication by 12 months to three years follow up<BR/>At 12 months, we found fewer participants in the psychotherapy groups needed additional medications compared with those who received medication (1 RCT, n=74, RR 0.64 CI 0.5 to 0.8, NNT 3 CI 3 to 6), and also at three years follow up (1 RCT, n=87, RR 0.85 CI 0.8 to 1.0, NNT 7 CI 5 to 26, <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>).</P>
<P>1.4 Global impression: Achieved best level of health at two years (Menninger Health Sickness Scale, high=better)<BR/>We found participants who took medication achieved the 'best level of health' by the care team (1 RCT, n=92, MD -5.8 CI -10 to -1.6, <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>) compared with the individual psychotherapy group.</P>
<P>1.5 Global impression: Treatment not considered successful by treatment team<BR/>Participants who received individual psychodynamic therapy were more likely to have been treated unsuccessfully by the treatment team than those who received drug therapy alone (1 RCT, n=92, RR 16.4 CI 2.3 to 118.8, NNH 4 CI 2 to 39, <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>).</P>
<P>1.6 Global impression: Hospital re-admission<BR/>We found no significant difference in the rates of re-hospitalisation between psychotherapy without medication and those given medication alone (1 RCT, n=24, RR 0.63 CI 0.3 to 1.4, <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>).<BR/>
</P>
<P>1.7 Leaving the study early<BR/>During long-term evaluation we found no significant difference in study attrition (1 RCT, n=94, RR 1.04 CI 0.3 to 3.9, <LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>).</P>
<P>2. COMPARISON 2. INDIVIDUAL PSYCHODYNAMIC PSYCHOTHERAPY AND MEDICATION versus MEDICATION<BR/>
<LINK REF="STD-May-1976" TYPE="STUDY">May 1976</LINK> is the only study included in this comparison.</P>
<P>2.1 Committed suicide<BR/>We found no clear difference in participants receiving individual therapy plus medication and those given only medication (1 RCT, n=92, RR 0.16 CI 0.01 to 2.9, <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>). Three people who only received medication committed suicide by three years, with nobody receiving medication and individual therapy killing themselves.</P>
<P>2.2 Global impression: Not able to be discharged<BR/>No significant differences were found in discharge eligibility between individual therapy combined with antipsychotic drugs and drugs alone (1 RCT, n=92, RR 1.09 CI 0.2 to 7.4, <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>).</P>
<P>2.3 Global impression: given additional medication or received medication by 12 months to three years follow up<BR/>We found no significant difference between the two groups for the outcome of being given additional medication at 12 months (1 RCT, n=86, RR 0.95 CI 0.9 to 1.1) or at three years (1 RCT, n=90, RR 0.95 CI 0.9 to 1.0, <LINK REF="CMP-002.03" TYPE="ANALYSIS">Analysis 2.3</LINK>).</P>
<P>2.4 Global impression: Achieved best level of health (Menninger Health Sickness scale: high=good)<BR/>From the health sickness scales, we found no significant difference between groups for having achieved the best level of health (1 RCT, n=90, MD -0.80 CI -5.4 to 3.8, <LINK REF="CMP-002.04" TYPE="ANALYSIS">Analysis 2.4</LINK>).</P>
<P>2.5 Global impression: Treatment not considered successful by treatment team<BR/>No significant differences were found for the outcome of 'treatment not considered successful' (1 RCT, n=92, RR 2.18 CI 0.2 to 23.2, <LINK REF="CMP-002.05" TYPE="ANALYSIS">Analysis 2.5</LINK>) between the two groups.</P>
<P>2.6 Global impression: Hospital re-admission<BR/>We found rates of re-hospitalisation in long-term analysis were equivocal between psychotherapy with medication and participants given only medication (1 RCT, n=24, RR 1.00 CI 0.4 to 2.6, <LINK REF="CMP-002.06" TYPE="ANALYSIS">Analysis 2.6</LINK>).<BR/>
</P>
<P>2.7 Leaving the study early<BR/>During long-term evaluation we found study attrition to be equivocal (1 RCT, n=94, RR 0.82 CI 0.2 to 3.5, <LINK REF="CMP-002.07" TYPE="ANALYSIS">Analysis 2.7</LINK>).</P>
<P>3. COMPARISON 3. INSIGHT-ORIENTED PSYCHODYNAMIC PSYCHOTHERAPY versus REALITY-ADAPTIVE PSYCHOTHERAPY<BR/>3.1 Global impression<BR/>Data on ability to perform major household tasks (n=164, RR 1.1 CI 1.0 to 1.3, p=0.06) almost reached statistical significance in the <LINK REF="STD-Gunderson-1984" TYPE="STUDY">Gunderson 1984</LINK> trial. No significant differences were found between groups for enjoying major relationships (1 RCT, n=164, RR 1.1 CI 1.0 to 1.2). For the outcome of not being self-supporting, we again found no significant difference between groups (1 RCT, n=164, RR 1.05 CI 0.9 to 1.2). For the outcome of re-hospitalisation we found no significant difference between the psychodynamic approach and the more cognitive-based therapy (1 RCT, n=164, RR 1.20 CI 0.9 to 1.6, <LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>).</P>
<P>3.2 Leaving the study early<BR/>People receiving the psychodynamic approach were more likely to continue in the study than those allocated to reality-adaptive therapy at six months (1 RCT, n=164, RR 0.46 CI 0.3 to 0.7, NNT 3 CI 3 to 6), at 12 months (1 RCT, n=164, RR 0.46 CI 0.3 to 0.6, NNT 2 CI 2 to 4) and at 24 months (1 RCT, n=164, RR 0.54 CI 0.4 to 0.7, NNT 2 CI 2 to 3, <LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>).</P>
<P>4. COMPARISON 4. INDIVIDUAL PSYCHODYNAMIC PSYCHOTHERAPY versus GROUP PSYCHOTHERAPY<BR/>4.1 Global impression<BR/>For the outcome of 'returned to hospital' we found no significant difference between the therapies at one and two years in the <LINK REF="STD-O_x0027_Brien-1972" TYPE="STUDY">O'Brien 1972</LINK> study. For global state 'not improved' we found no significant difference between groups (1 RCT, n=100, RR 1.27 CI 1.0 to 1.7). We found no significant difference in the number of participants who were actively discharged from therapy at two years (1 RCT, n=100, RR 0.60 CI 0.3 to 1.1). Twelve month data were equivocal. Fewer participants remained in therapy in the individual psychodynamic group at 12 months compared with group psychotherapy, although the upper confidence interval reached the line of no effect (1 RCT, n=100, RR 0.68 CI 0.5 to 1.0, <LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>). Two year data were equivocal.</P>
<P>5. COMPARISON 5. INDIVIDUAL PSYCHODYNAMIC PSYCHOTHERAPY WITH MEDICATION versus INDIVIDUAL PSYCHODYNAMIC PSYCHOTHERAPY<BR/>5.1 Global impression: Re-hospitalisation<BR/>We found rates of re-hospitalisation during long-term analyses were equivocal in participants receiving psychotherapy with medication, and psychotherapy without medication (1 RCT, n=24, RR 1.00 CI 0.4 to 2.6, <LINK REF="CMP-005.01" TYPE="ANALYSIS">Analysis 5.1</LINK>).</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2010-02-16 15:09:28 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2010-02-16 15:08:22 +0000" MODIFIED_BY="[Empty name]">
<P>Before any summary of the findings are presented we think it is important to remember that no comparison has more than 164 people in any trial. The trials are pioneering and important - but very, very small and any finding or suggestion of a finding should be replicated.</P>
<P>1. COMPARISON 1. INDIVIDUAL PSYCHODYNAMIC THERAPY versus MEDICATION<BR/>1.1 Suicide<BR/>During three years of participant evaluation, psychodynamic therapy does not appear to reduce the risk of suicide compared with standard care. This is based on few events in small numbers of people.</P>
<P>1.2 Global impression<BR/>All treatment took place in hospital and participants were discharged when ready to go home. More people on medication only were eligible for discharge than those allocated to the psychodynamic group. Although numbers are small (n=92) this is a strong finding (RR 8.35 CI 2.0 to 34.3, <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>) that most clinicians would find intuitive.</P>
<P>Unsurprisingly, those who were randomised to receive medication only as part of the trial either continued to receive, or received additional medication at 12 months and three years (46/48 at 12 months; 48/48 at three years). What is surprising, though, is that those who received individual therapy did not, on the whole, go on to receive medication. It seems that, upon reading the reports of the trials, those who participated were not discharged from hospital on medication, but only received it for the duration of their stay. This outcome reports on the number of people who received prescriptions for medication after being discharged from hospital. At 12 months, statistical significance is found between the two groups for those who received individual therapy and those who received medication only, with psychotherapy needing to be given to three people to avoid one extra person receiving medication (NNT 3 CI 3 to 6). Those who did not receive medication in hospital, as part of the study, continued to be less likely to receive medication outside of hospital at three years also (NNT 7 CI 5 to 26). However, when continuous data are presented for having achieved best level of health, those who received medication were deemed to have a better outcome than those who received therapy alone. Using these two results and taking the outcome of 'not considered to have been treated successfully', (15/46 versus 1/48, NNH 4 CI 2 to 39), the clinician would need to be certain of their reasons for not implementing medication. Individual psychodynamic therapy seems no better - and probably worse - than medication for people with schizophrenia and the therapy may have a longer term effect in discouraging the use of medication - and in this way could have deleterious effects of considerable duration.</P>
<P>1.3 Hospital re-admission<BR/>Participants who received psychodynamic therapy faired no better than people given only standard care for the outcome of hospital re-admission, but this is based upon a small sample (n=24, <LINK REF="STD-Karon-1981" TYPE="STUDY">Karon 1981</LINK>) and is under powered making such an evaluation unreliable.<BR/>
</P>
<P>1.4 Leaving the study early<BR/>Study attrition is only reported in the <LINK REF="STD-May-1976" TYPE="STUDY">May 1976</LINK> with only four participants leaving early from each group (4/46, 4/48), which is low by the standards of modern schizophrenia randomised controlled trials.<BR/>
</P>
<P>2. Comparison 2. INDIVIDUAL PSYCHODYNAMIC PSYCHOTHERAPY AND MEDICATION versus MEDICATION<BR/>The core of any discussion for this comparison is that there are too few data to make firm conclusions. There are some interesting findings but all data are few, out of date and of limited quality.</P>
<P>2.1 Suicide<BR/>We found no significant advantage for the use of psychodynamic therapy in combination with antipsychotic drugs for preventing suicide compared with participants given only medication. Perhaps a larger study may have shown significant differences - <LINK REF="STD-May-1976" TYPE="STUDY">May 1976</LINK> evaluated outcomes from only 92 people.</P>
<P>2.2 Global impression<BR/>From limited data (<LINK REF="STD-May-1976" TYPE="STUDY">May 1976</LINK>, n=92) we found no significant advantage for the use of psychodynamic therapy in combination with antipsychotic drugs for the outcomes 'not able to be discharged', 'needing additional medication' or for achieving the best level of health from the Menninger Health Sickness scale, compared with participants given only antipsychotics.</P>
<P>2.3 Hospital re-admission<BR/>We did not find any significant difference in re-hospitalisation rates between psychodynamic therapy plus antipsychotics, and participants given only standard care. Again hospital re-admission is only evaluated by <LINK REF="STD-Karon-1981" TYPE="STUDY">Karon 1981</LINK> with a total of 24 participants included in the analysis.<BR/>
</P>
<P>2.4 Treatment not considered successful by treatment team<BR/>'Successful treatment' as judged by a treatment team did not reveal any significant advantage for the psychodynamic therapy and antipsychotics group compared with standard care treatment (<LINK REF="STD-May-1976" TYPE="STUDY">May 1976</LINK>, n=92).</P>
<P>2.5 Leaving the study early<BR/>Again, we could only extract data on study attrition from <LINK REF="STD-May-1976" TYPE="STUDY">May 1976</LINK>. Only three participants left early from the combined psychodynamic therapy plus antipsychotic group, and four left from the drugs only group (3/44, 4/48) suggesting that psychodynamic therapy combined with antipsychotics is no less acceptable to participants than standard care.</P>
<P>3. COMPARISON 3. INSIGHT-ORIENTED PSYCHODYNAMIC PSYCHOTHERAPY versus REALITY-ADAPTIVE PSYCHOTHERAPY<BR/>3.1 Global impression<BR/>The largest of the four included studies (<LINK REF="STD-Gunderson-1984" TYPE="STUDY">Gunderson 1984</LINK>, n=164) reported outcomes for ability to perform household tasks, enjoy major relationships, re-hospitalisation and not being able to self-support, and we found no significant difference between groups. This is in keeping with other findings that there is little differences between different psychotherapeutic approaches when it comes to several aspects of mental health.</P>
<P>3.2 Leaving the study early<BR/>Psychodynamic therapy proved to be more acceptable to participants than reality-adaptive therapy in this unusual and highly selective study at six months (NNT 3 CI 3 to 6), 12 months (NNT 2 CI 2 to 4) and at 24 months (NNT 2 CI 2 to 3) with significantly fewer leaving the study early. This finding is in need of replication.</P>
<P>4. COMPARISON 4. INDIVIDUAL PSYCHODYNAMIC PSYCHOTHERAPY versus GROUP PSYCHOTHERAPY<BR/>4.1 Global impression<BR/>The <LINK REF="STD-O_x0027_Brien-1972" TYPE="STUDY">O'Brien 1972</LINK> study reported outcome data for global state 'not improved', 'number of patients actively discharged from therapy' and 'remaining in therapy' and we found no significant differences between individual psychodynamic therapy and the more cost efficient therapeutic group approach. Considering how cost-efficient group therapy could be this is type of comparison should be considered again for almost any psychotherapeutic approach.</P>
<P>5. COMPARISON 5. INDIVIDUAL PSYCHODYNAMIC PSYCHOTHERAPY WITH MEDICATION versus INDIVIDUAL PSYCHODYNAMIC PSYCHOTHERAPY<BR/>5.1 Re-hospitalisation<BR/>We were only able to include one study for this comparison (<LINK REF="STD-Karon-1981" TYPE="STUDY">Karon 1981</LINK>) and from limited data (n=24) no significant differences emerged. It is not clear that there are additive effects of individual psychodynamic psychotherapy to medication, but, again, this study is under powered and a larger sample size is needed to be able to detect any treatment effect.<BR/>
</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2010-02-16 15:09:28 +0000" MODIFIED_BY="[Empty name]">
<P>1. General<BR/>All studies were set in North America and mostly randomised participants without operationally diagnosed disorders. Participants also seemed to have illnesses uncomplicated by co-morbidity. The inclusion criteria were so strict in <LINK REF="STD-Gunderson-1984" TYPE="STUDY">Gunderson 1984</LINK> (diagnosis of schizophrenia, DSM II &amp; III, confirmed three times and only 164 out of nearly 2000 screened), it is likely that people entering the study were not like those seen in clinical practice. How participants in <LINK REF="STD-May-1976" TYPE="STUDY">May 1976</LINK> resemble those normally seen in practice is hard to know, with entry criteria of 'not likely to improve' and those who responded quickly being excluded. <LINK REF="STD-Karon-1981" TYPE="STUDY">Karon 1981</LINK> intended to include participants who were acutely ill with no previous hospitalisations but it emerged that a third of participants had withheld relevant information during the screening and had been previously hospitalised.</P>
<P>2. Limited data<BR/>The collection and quality of reporting of data is disappointing, although the outcomes measured do have more clinical meaning than much scale-derived data commonly reported in trials (<LINK REF="REF-Thornley-1998" TYPE="REFERENCE">Thornley 1998</LINK>). Where continuous data were reported, such as days in hospital, means and standard deviations were not given, or data were presented in graphs that made it impossible to extract useful information. Much data were unable to be included in this review as a result of inadequate reporting. There seemed to be no consideration given to adverse effects from the treatments in the included studies.</P>
<P>3. Psychoanalytic therapy<BR/>No trials were identified investigating the value of a psychoanalytic approach for people with schizophrenia.</P>
<P>4. Sensitivity analysis and publication bias<BR/>We were unable to undertake the proposed funnel graph for publication bias or undertake a sensitivity analysis for the effects of including studies with high attrition versus those with lower loss to follow up. Despite not being able to undertake a funnel plot for publication bias, the absence of any controlled studies that have attempted to replicate the included studies surprises us, and leads us to question whether there is a bias away from research in this understudied area.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2009-07-29 11:04:25 +0100" MODIFIED_BY="[Empty name]">
<P>The quality of reporting in most studies was poor. There are likely to be significant biases in the results favouring psychodynamic-psychotherapy. The magnitude of the effects of these biases on, for example, the primary outcome, could be considerable with an overestimate of 30% being entirely credible (<LINK REF="REF-J_x00fc_ni-2001" TYPE="REFERENCE">Jüni 2001</LINK>).<BR/>
</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2009-08-07 12:16:01 +0100" MODIFIED_BY="[Empty name]">
<P>We have only been able to identify a small number of studies that were published in the 1970s and 1980s and each study used its own approach to psychodynamic psychotherapy and therefore they do not necessarily reflect current practice.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2009-08-07 12:16:16 +0100" MODIFIED_BY="[Empty name]">
<P>This review updates and improves past work and agrees with findings from previous versions.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2010-02-16 15:26:41 +0000" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2010-01-11 11:51:05 +0000" MODIFIED_BY="[Empty name]">
<P>There are too few data to guide clinical implications with confidence.</P>
<P>1. People with schizophrenia<BR/>Taking medication seems far more effective than psychodynamic therapy for helping achieve hospital discharge. Although all other data are sparse, there is no indication of any beneficial effect at all of psychodynamic therapy for those with schizophrenia, except if you consider not being given additional medication in the twelve months to three years after discharge. Those receiving psychotherapy alone were less likely to be seen as treated successfully or achieving best level of health, compared to those who received medication alone. When compared to a more cognitive approach, psychodynamic therapy may be more acceptable, but data on possible harm were not recorded.</P>
<P>2. Clinicians<BR/>People receiving an insight-oriented psychodynamic therapy tend to stay in contact with therapists longer than those receiving a more cognitive-based reality adaptive therapy, but there is little evidence of any positive effect from a psychodynamic approach. This is due to a lack of evidence, rather than a presence of evidence which demonstrates a lack of positive effect. There are some hints from the data that a group approach may be a cost effective way of providing the intervention - but that the intervention may put people off taking medication. </P>
<P>3. Managers or policy makers<BR/>More recent therapies have eclipsed the psychodynamic approach for schizophrenia (<LINK REF="REF-Jones-1999" TYPE="REFERENCE">Jones 1999</LINK>) but the psychodynamic approach could still be of value - we do not have the data to dismiss its effects entirely.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2010-02-16 15:26:41 +0000" MODIFIED_BY="[Empty name]">
<P>1. General<BR/>If any studies are being conducted or planned they should strictly adhere to the CONSORT statement (<LINK REF="REF-Begg-1996" TYPE="REFERENCE">Begg 1996</LINK>, <LINK REF="REF-Moher-2001" TYPE="REFERENCE">Moher 2001</LINK>, <A HREF="http://www.consort.org">CONSORT</A>) in order to present usable data.</P>
<P>2. Specific<BR/>It is feasible that real effects of psychodynamic therapy have been missed through poor recording, or loss of limited data, or because the trials just have not been done. Funding for a randomised trial would probably be difficult to acquire. Nevertheless, should psychodynamic therapy be recommended for someone with schizophrenia it should, if possible, be given within a context of a well-designed, clinically relevant randomised trial (see <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK> for a suggestion of a design). Data relating to hospitalisation, role function, independence, mental state and behaviour need replication and expansion. More high-quality trial-derived data relating to satisfaction with care, social functioning, family burden, employment and adverse effects would be of great interest. Data on psychotherapy effects in people who are not in hospital are missing.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2010-01-11 11:32:38 +0000" MODIFIED_BY="[Empty name]">
<P>The past and present editors and staff of the Cochrane Schizophrenia Group's editorial base are acknowledged for their help and comments. Deborah Stacey and Hannu Juvonen are also acknowledged for their help at the protocol stage and Hannu Juvonen for comments on the finished review.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2009-08-13 14:59:19 +0100" MODIFIED_BY="[Empty name]">
<P>Mark Fenton: has been a patient in both individual and group psychoanalytic psychotherapy and worked as a nurse psychotherapist in the National Health System (UK) and believes that psychoanalytic treatment has a place in any healthcare system.<BR/>Lena Malmberg: works as a doctor on a psychodynamically-oriented rehabilitation unit for patients living in the community with schizophrenia in Porvoo, Finland.<BR/>John Rathbone: none known.<BR/>
</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2009-08-07 12:22:22 +0100" MODIFIED_BY="[Empty name]">
<P>Lena Malmberg - prepared protocol, selected and acquired studies, extracted data, summated data, produced report.<BR/>Mark Fenton - prepared protocol, selected studies, extracted data, summated data, produced report.<BR/>John Rathbone - selected studies, extracted data, summated data, produced report.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2009-02-26 16:18:50 +0000" MODIFIED_BY="[Empty name]">
<P>Upgrade of review into RevMan 5 resulted in changed order of text within '<LINK TAG="METHODS" TYPE="SECTION">Methods</LINK>' section but no fundamental changes to the conduct of the review or the update.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES>
<P>This review has undergone external peer review and internal editorial review.</P>
</PUBLIC_NOTES>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2010-02-03 18:48:27 +0000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2010-02-03 18:33:56 +0000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2010-02-03 18:32:59 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Gunderson-1984" MODIFIED="2010-02-03 18:32:59 +0000" MODIFIED_BY="[Empty name]" NAME="Gunderson 1984" YEAR="1984">
<REFERENCE MODIFIED="2008-12-12 10:39:47 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Frank AF, Gunderson JG</AU>
<TI>The role of the therapeutic alliance in the treatment of schizophrenia. Relationship to course and outcome</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1990</YR>
<VL>47</VL>
<PG>228-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-02-03 18:32:40 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Gunderson JG, Frank AF, Katz HM, Vannicelli ML, Frosch JP, Knapp PH</AU>
<TI>Effects of psychotherapy in schizophrenia. II. Comparative outcome of two forms of treatment</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>1984</YR>
<VL>10</VL>
<NO>4</NO>
<PG>564-98</PG>
<IDENTIFIERS MODIFIED="2010-02-03 18:32:40 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gunderson JG, Frank AF</AU>
<TI>Effects of psychotherapy in schizophrenia</TI>
<SO>Yale Journal of Biological Medicine</SO>
<YR>1985</YR>
<VL>58</VL>
<NO>4</NO>
<PG>373-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-02-03 18:32:59 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stanton AH, Gunderson JG, Knapp PH, Frank AF, Vannicelli ML, Schnitzer R, Rosenthal R</AU>
<TI>Effects of psychotherapy in schizophrenia. I. Design and implementation of a controlled study</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>1984</YR>
<VL>10</VL>
<NO>4</NO>
<PG>520-63</PG>
<IDENTIFIERS MODIFIED="2010-02-03 18:32:59 +0000" MODIFIED_BY="[Empty name]"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Karon-1981" MODIFIED="2009-02-02 11:58:47 +0000" MODIFIED_BY="[Empty name]" NAME="Karon 1981" YEAR="1981">
<REFERENCE MODIFIED="2009-02-02 11:58:47 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Karon BP, Vandenbos GR</AU>
<TI>Psychotherapy of schizophrenia: The treatment of choice</TI>
<SO>Psychoanalytic Review</SO>
<YR>1981</YR>
<VL>71</VL>
<PG>505-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-May-1976" MODIFIED="2009-03-03 08:26:19 +0000" MODIFIED_BY="[Empty name]" NAME="May 1976" YEAR="1976">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>May PR, Tuma AH, Dixon WJ, Yale C, Theile DA, Kraude WH</AU>
<TI>Schizophrenia: a follow-up study of results of treatment. II. Hospital stay over two to five years</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1976</YR>
<VL>33</VL>
<NO>4</NO>
<PG>481-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="76230762"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>May PR, Tuma AH, Dixon WJ</AU>
<TI>Schizophrenia: a follow-up study of results of treatment. I. Design and other problems</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1976</YR>
<VL>33</VL>
<NO>4</NO>
<PG>474-8</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="76230761"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>May PR, Tuma AH, Dixon WJ</AU>
<TI>Schizophrenia: a follow-up study of the results of five forms of treatment</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1981</YR>
<VL>38</VL>
<NO>7</NO>
<PG>776-84</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-03-03 08:26:19 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>May PR, Tuma AH</AU>
<TI>The Paul H. Hoch award lecture: a follow up study of the results of treatment of schizophrenia</TI>
<SO>Proceedings of the Annual Meeting of the American Psychopathological Association</SO>
<YR>1976</YR>
<VL>64</VL>
<PG>256-84</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="76176411"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>May PR, Tuma AH</AU>
<TI>Treatment of schizophrenia: an experimental study of five treatments</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1965</YR>
<VL>111</VL>
<PG>503-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tuma AH, May PR, Yale C, Forsythe AB</AU>
<TI>Therapist characteristics and the outcome of treatment in schizophrenia</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1978</YR>
<VL>35</VL>
<PG>81-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tuma AH, May PR, Yale C, Forsythe AB</AU>
<TI>Therapist experience, general clinical ability, and treatment outcome in schizophrenia</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>1978</YR>
<VL>46</VL>
<NO>5</NO>
<PG>1120-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tuma H, May P</AU>
<TI>Psychotherapy, drugs and therapist experience in the treatment of schizophrenia: a critique of the Michigan State Project</TI>
<SO>Psychotherapy Theory, Research and Practice</SO>
<YR>1975</YR>
<VL>12</VL>
<NO>2</NO>
<PG>138-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-O_x0027_Brien-1972" NAME="O'Brien 1972" YEAR="1972">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mintz J, O'Brien C, Luborsky L</AU>
<TI>Predicting the outcome of psychotherapy for schizophrenics: relative contributions of patient, therapist, and treatment characteristics</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1976</YR>
<VL>33</VL>
<NO>10</NO>
<PG>1183-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>O'Brien CP, Hamm KB, Ray BA, Pierce JF</AU>
<TI>Group versus individual psychotherapy with schizophrenics</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1972</YR>
<VL>27</VL>
<PG>474-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2010-02-03 18:33:56 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Appelbaum-1986" NAME="Appelbaum 1986" YEAR="1986">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Appelbaum AH, Munich RL</AU>
<TI>Reinventing moral treatment: the effects upon patients and staff members of a program of psychosocial rehabilitation</TI>
<SO>Psychiatric Hospital</SO>
<YR>1986</YR>
<VL>17</VL>
<NO>1</NO>
<PG>11-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Armstrong-1991" NAME="Armstrong 1991" YEAR="1991">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Armstrong HE, Cox GB, Short BA, Allmon DJ</AU>
<TI>A comparative evaluation of two day treatment programs</TI>
<SO>Psychosocial Rehabilitation Journal</SO>
<YR>1991</YR>
<VL>14</VL>
<NO>4</NO>
<PG>53-67</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Azima-1959" NAME="Azima 1959" YEAR="1959">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Azima H, Azima FJ, Durost HB</AU>
<TI>Psychoanalytic formations of effects of reserpine on schizophrenic organization</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1959</YR>
<VL>1</VL>
<PG>662-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bellak-1973" NAME="Bellak 1973" YEAR="1973">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bellak L, Chassan JB, Gediman HK, Hurvich M</AU>
<TI>Ego function assessment of analytic psychotherapy combined with drug therapy</TI>
<SO>Journal of Nervous and Mental Disease</SO>
<YR>1973</YR>
<VL>157</VL>
<NO>6</NO>
<PG>465-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cancro-1987" NAME="Cancro 1987" YEAR="1987">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Cancro R</AU>
<TI>Schizophrenic disturbances</TI>
<TO>Os disturbios esquizofrenicos</TO>
<SO>Jornal Brasileiro de Psiquiatria</SO>
<YR>1987</YR>
<VL>36</VL>
<NO>2</NO>
<PG>85-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carpenter-1984" MODIFIED="2010-02-03 18:33:56 +0000" MODIFIED_BY="[Empty name]" NAME="Carpenter 1984" YEAR="1984">
<REFERENCE MODIFIED="2010-02-03 18:33:56 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carpenter WT</AU>
<TI>A perspective on the psychotherapy of schizophrenia project</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>1984</YR>
<VL>10</VL>
<NO>4</NO>
<PG>599-603</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carpenter-1993" NAME="Carpenter 1993" YEAR="1993">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Carpenter WT</AU>
<TI>Commentary: psychosocial treatment of schizophrenia</TI>
<SO>Psychiatry</SO>
<YR>1993</YR>
<VL>56</VL>
<PG>301-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chiesa-1999" NAME="Chiesa 1999" YEAR="1999">
<REFERENCE PRIMARY="YES" TYPE="OTHER">
<AU>Chiesa M</AU>
<TI>Time limited psychosocial intervention with patients with severe personality disorder following short inpatient stay</TI>
<SO>National Research Register</SO>
<YR>1999</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chodoff-1982" NAME="Chodoff 1982" YEAR="1982">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Chodoff P</AU>
<TI>Assessment of psychotherapy: reflections of a practitioner</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1982</YR>
<VL>39</VL>
<NO>9</NO>
<PG>1097-103</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Cormier-1987" NAME="Cormier 1987" YEAR="1987">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Cormier HJ, Allard L, Vaillancourt S, Gingras C</AU>
<TI>An evaluation of mental health programs for young adult psychotics. [Special issue: community mental health services for the chronically mentally disabled]</TI>
<TO>Evaluation d'un programme de sante mentale pour jeunes adultes psychotiques</TO>
<SO>Canadian Journal of Community Mental Health</SO>
<YR>1987</YR>
<VL>6</VL>
<PG>107-16</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-De-Socarraz-1978" MODIFIED="2009-03-03 08:29:13 +0000" MODIFIED_BY="[Empty name]" NAME="De Socarraz 1978" YEAR="1978">
<REFERENCE MODIFIED="2009-03-03 08:29:13 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>De Socarraz ML, Randolph DL</AU>
<TI>Responses given by A and B quasi-therapists to differing sexual roles in an intropunitive-neurotic prototype: an analogue study</TI>
<SO>Journal of Clinical Psychology</SO>
<YR>1978</YR>
<VL>34</VL>
<NO>1</NO>
<PG>165-70</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="78151236"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Docherty-1984" MODIFIED="2009-11-30 10:41:41 +0000" MODIFIED_BY="[Empty name]" NAME="Docherty 1984" YEAR="1984">
<REFERENCE MODIFIED="2009-11-30 10:41:41 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Docherty PJ</AU>
<TI>O tempora, o mores: directions in research on the psychotherapeutic treatment of schizophrenia</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>1984</YR>
<VL>10</VL>
<NO>4</NO>
<PG>621-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Dyrud-1973" NAME="Dyrud 1973" YEAR="1973">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Dyrud J, Holzman P</AU>
<TI>The psychotherapy of schizophrenia: does it work?</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1973</YR>
<VL>130</VL>
<NO>6</NO>
<PG>670-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Epstein-1981" NAME="Epstein 1981" YEAR="1981">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Epstein N, Vlok L</AU>
<TI>Research on the results of psychotherapy: a summary of evidence</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1981</YR>
<VL>138</VL>
<NO>8</NO>
<PG>1027-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Falloon-1983" MODIFIED="2009-02-02 12:03:18 +0000" MODIFIED_BY="[Empty name]" NAME="Falloon 1983" YEAR="1983">
<REFERENCE MODIFIED="2009-02-02 12:03:09 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Falloon I, Razani J, Moss HB, Boyd JL, McGill CW, Pederson J</AU>
<TI>Community management of schizophrenia. A one-year study of family and individual therapy</TI>
<TO>Gemeindenahe Versorgung von Schizophrenen. Eine einjahringe Kontrolluntersuchung bei Familien und Einzeltherapie</TO>
<SO>Partnerberatung</SO>
<YR>1983</YR>
<VL>20</VL>
<NO>2-3</NO>
<PG>73-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-02-02 12:03:18 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Falloon IRH, Boyd JL, McGill CW, Williamson M, Razani J, Moss HB</AU>
<TI>Family management in the prevention of morbidity of schizophrenia: clinical outcome of a two-year longitudinal study</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1985</YR>
<VL>42</VL>
<NO>9</NO>
<PG>887-96</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Falloon IRH, McGill CW, Boyd JL, Pederson J</AU>
<TI>Family management in the prevention of morbidity of schizophrenia: social outcome of a two-year longitudinal study</TI>
<SO>Psychological Medicine</SO>
<YR>1987</YR>
<VL>17</VL>
<NO>1</NO>
<PG>59-66</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Friedman-1973" NAME="Friedman 1973" YEAR="1973">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Friedman R, Gunderson J, Feinsilver D</AU>
<TI>The psychotherapy of schizophrenia: an NIMH program</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1973</YR>
<VL>130</VL>
<NO>6</NO>
<PG>674-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gabbard-1997" NAME="Gabbard 1997" YEAR="1997">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Gabbard G, Lazar S, Hornberger J, Spiegel D</AU>
<TI>The economic impact of psychotherapy: a review</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1997</YR>
<VL>154</VL>
<NO>2</NO>
<PG>147-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gillieron-1980" MODIFIED="2009-03-03 08:30:43 +0000" MODIFIED_BY="[Empty name]" NAME="Gillieron 1980" YEAR="1980">
<REFERENCE MODIFIED="2009-03-03 08:30:43 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Gillieron E, Bovet J</AU>
<TI>Evaluation of psychotherapies and osgood's semantic differential: a tentative approach</TI>
<SO>Psychotherapy and Psychosomatics</SO>
<YR>1980</YR>
<VL>33</VL>
<NO>1-2</NO>
<PG>46-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Glick-1974" NAME="Glick 1974" YEAR="1974">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Glick ID, Hargreaves WA, Goldfield M</AU>
<TI>Short versus long hospitalization: a prospective controlled study. I. The preliminary results of a one-year follow-up of schizophrenics</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1974</YR>
<VL>30</VL>
<NO>3</NO>
<PG>363-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Glick ID, Hargreaves WA, Raskin M, Kutner SJ</AU>
<TI>Short versus long hospitalization: a prospective controlled study. II. Results for schizophrenic inpatients</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1975</YR>
<VL>132</VL>
<NO>4</NO>
<PG>385-90</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1919"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Green-1984" MODIFIED="2009-03-03 09:25:17 +0000" MODIFIED_BY="[Empty name]" NAME="Green 1984" YEAR="1985">
<REFERENCE MODIFIED="2009-03-03 09:24:47 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="BOOK">
<AU>Green D</AU>
<SO>The effect of psychotherapy on the schizophrenic's human percept: a study of object representations in schizophrenia</SO>
<YR>1984</YR>
<PB>Univ. of Michigan State</PB>
<CY>Michigan, USA</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Guthrie-1997" NAME="Guthrie 1997" YEAR="1997">
<REFERENCE PRIMARY="YES" TYPE="OTHER">
<AU>Guthrie E</AU>
<TI>Cost effectiveness of psychotherapy for treatment resistant psychiatric outpatients</TI>
<SO>National Research Register</SO>
<YR>1997</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Harding-1994" MODIFIED="2009-03-03 08:42:35 +0000" MODIFIED_BY="[Empty name]" NAME="Harding 1994" YEAR="1994">
<REFERENCE MODIFIED="2008-12-12 10:48:56 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Harding C, Zahniser J</AU>
<TI>Empirical correction of seven myths about schizophrenia with implications for treatment</TI>
<SO>Acta Psychiatrica Scandinavica</SO>
<YR>1994</YR>
<VL>384</VL>
<PG>140-6</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="95185335"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hogarty-1997" MODIFIED="2009-02-02 12:05:18 +0000" MODIFIED_BY="[Empty name]" NAME="Hogarty 1997" YEAR="1997">
<REFERENCE MODIFIED="2009-02-02 12:05:18 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hogarty G, Kornblith S, Greenwald D, DiBarry A, Cooley S, Ulrich R</AU>
<TI>Three-year trials of personal therapy among schizophrenic patients living with or independent of family. 1. Description of study and effects of relapse rates</TI>
<SO>American Journal of Psychiatry</SO>
<YR>1997</YR>
<VL>154</VL>
<NO>11</NO>
<PG>1504-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Jones-2001" MODIFIED="2009-03-02 11:12:00 +0000" MODIFIED_BY="[Empty name]" NAME="Jones 2001" YEAR="2001">
<REFERENCE MODIFIED="2009-03-02 11:11:57 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Jones P</AU>
<TI>INSIGHT - Institute - Nottingham - Salford Investigation of group hallucinations treatment</TI>
<SO>National Research Register</SO>
<YR>2001</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kaplan-1985" NAME="Kaplan 1985" YEAR="1985">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kaplan R, Thornton P, Silverman L</AU>
<TI>Further data on the effects of subliminal symbiotic stimulation on schizophrenics</TI>
<SO>Journal of Nervous and Mental Diseases</SO>
<YR>1985</YR>
<VL>173</VL>
<NO>11</NO>
<PG>658-66</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Karon-1969" NAME="Karon 1969" YEAR="1969">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Karon BP, VandenBos GR</AU>
<TI>Intellectual test changes in schizophrenic patients in the first six months of treatment</TI>
<SO>Psychotherapy Theory Research and Practice</SO>
<YR>1969</YR>
<VL>6</VL>
<NO>2</NO>
<PG>88-96</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Karon BP, Vandenbos GR</AU>
<TI>Experience, medication and the effectiveness of psychotherapy with schizophrenics</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1970</YR>
<VL>116</VL>
<PG>427-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Karon BP, Vandenbos GR</AU>
<TI>The consequences of psychotherapy for schizophrenia patients</TI>
<SO>Psychotherapy Theory Research and Practice</SO>
<YR>1972</YR>
<VL>9</VL>
<NO>2</NO>
<PG>111-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Karon BP, Vandenbos GR</AU>
<TI>Thought disorder in schizophrenia, length of hospitalization, and clinical status ratings: validity for the Feldman-Drasgow Visual-Verbal Test</TI>
<SO>Journal of Clinical Psychology</SO>
<YR>1974</YR>
<VL>30</VL>
<NO>3</NO>
<PG>264-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Karon-1984" NAME="Karon 1984" YEAR="1984">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Karon BP</AU>
<TI>The fear of reducing medication, and where have all the patients gone?</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>1984</YR>
<VL>10</VL>
<NO>4</NO>
<PG>613-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Klerman-1984" NAME="Klerman 1984" YEAR="1984">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Klerman GL</AU>
<TI>Ideology and science in the individual psychotherapy of schizophrenia</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>1984</YR>
<VL>10</VL>
<NO>4</NO>
<PG>608-12</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1919"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Krull-1987" NAME="Krull 1987" YEAR="1987">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Krull, F</AU>
<TI>Individual psychotherapy of schizophrenia: a review of theories and therapeutic practice</TI>
<TO>Psychotherapie bei schizophrenie: theorie und praxis der einzelbehandlung: eine Übersicht</TO>
<SO>Fortschritte der Neurologie Psychiatrie</SO>
<YR>1987</YR>
<VL>55</VL>
<NO>2</NO>
<PG>54-67</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lindberg-1981" MODIFIED="2009-03-03 08:38:57 +0000" MODIFIED_BY="[Empty name]" NAME="Lindberg 1981" YEAR="1981">
<REFERENCE MODIFIED="2009-03-03 08:38:57 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Lindberg D</AU>
<TI>A controlled study of five years' treatment with psychotherapy in combination with depot neuroleptics in schizophrenia. II. Personality changes measured by ten selected rorschach variables</TI>
<SO>Acta Psychiatrica Scandinavica</SO>
<YR>1981</YR>
<VL>Suppl 289</VL>
<PG>56-66</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="81130167"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2008-12-12 10:46:38 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lindberg D</AU>
<TI>Personality changes in chronic schizophrenic patients during five years' treatment with intensive psychotherapy in combination with depot neuroleptics. I. Analysis of changes as measured by the Holtzman Inkblot Technique</TI>
<SO>Acta Psychiatrica Scandinavica</SO>
<YR>1981</YR>
<VL>Suppl 289</VL>
<PG>27-55</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="81130166"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Luborsky-1975" MODIFIED="2009-03-03 08:40:52 +0000" MODIFIED_BY="[Empty name]" NAME="Luborsky 1975" YEAR="1975">
<REFERENCE MODIFIED="2009-03-03 08:40:52 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;the title seems wrong - won/one but this is how it appears on pubmed&lt;/p&gt;" NOTES_MODIFIED="2009-03-03 08:40:52 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Luborsky L, Singer B, Luborsky L</AU>
<TI>Comparative studies of psychotherapies. Is it true that "everywon has one and all must have prizes"?</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1975</YR>
<VL>32</VL>
<NO>8</NO>
<PG>995-1008</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Matthews-1981" MODIFIED="2009-11-30 13:24:27 +0000" MODIFIED_BY="[Empty name]" NAME="Matthews 1981" YEAR="1982">
<REFERENCE MODIFIED="2009-11-30 13:24:22 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="BOOK">
<AU>Matthews J</AU>
<SO>The process and outcome of therapy of outpatient schizophrenics by A and B therapists: does psychotherapy add to the effects of psychopharmacotherapy?</SO>
<YR>1981</YR>
<PB>Univ. of Auburn</PB>
<CY>Auburn, USA</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Matussek-1974" NAME="Matussek 1974" YEAR="1974">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Matussek P, Triebel A</AU>
<TI>The effectiveness of psychotherapy in 44 schizophrenics</TI>
<TO>Die wirksamkeit der psychotherapie bei 44 schizophrenen</TO>
<SO>Nervenarzt</SO>
<YR>1974</YR>
<VL>45</VL>
<PG>569-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-May-1984" MODIFIED="2009-11-30 10:41:45 +0000" MODIFIED_BY="[Empty name]" NAME="May 1984" YEAR="1984">
<REFERENCE MODIFIED="2009-11-30 10:41:45 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>May P</AU>
<TI>A step forward in research on psychotherapy of schizophrenia</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>1984</YR>
<VL>10</VL>
<NO>4</NO>
<PG>604-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mueser-1990" NAME="Mueser 1990" YEAR="1990">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Mueser KT, Berenbaum H</AU>
<TI>Psychodynamic treatment of schizophrenia: is there a future?</TI>
<SO>Psychological Medicine</SO>
<YR>1990</YR>
<VL>20</VL>
<NO>2</NO>
<PG>253-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Muller-1978" NAME="Muller 1978" YEAR="1978">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Muller P</AU>
<TI>Depressive syndromes during schizophrenic psychoses</TI>
<TO>Depressive syndrome im verlauf schizophrener psychosen</TO>
<SO>Fortschritte der Medizin</SO>
<YR>1978</YR>
<VL>96</VL>
<PG>1518-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Muller-1984" MODIFIED="2009-11-30 10:41:49 +0000" MODIFIED_BY="[Empty name]" NAME="Muller 1984" YEAR="1984">
<REFERENCE MODIFIED="2009-11-30 10:41:49 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Muller C</AU>
<TI>Psychotherapy in schizophrenia: the end of the pioneers' period</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>1984</YR>
<VL>10</VL>
<NO>4</NO>
<PG>618-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Res.-committee-1975" NAME="Res. committee 1975" YEAR="1975">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Committee on Research</AU>
<TI>Pharmacotherapy and psychotherapy: paradoxes problems and progress</TI>
<SO>Report/Group for the Advancement of Psychiatry</SO>
<YR>1975</YR>
<VL>9</VL>
<NO>93</NO>
<PG>263-434</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="75150343"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Resch-1994" NAME="Resch 1994" YEAR="1994">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Resch F</AU>
<TI>Psychotherapeutic and sociotherapeutic aspects in children and adolescents with schizophrenia</TI>
<TO>Psychotherapeutische und soziotherapeutische Aspekte bei schizophrenen Psychosen des Kindes- und Jugendalters</TO>
<SO>Zeitschrift für Kinder- und Jugendpsychiatrie</SO>
<YR>1994</YR>
<VL>22</VL>
<NO>4</NO>
<PG>275-84</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="95159679"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Roback-1972" NAME="Roback 1972" YEAR="1972">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Roback HB</AU>
<TI>Experimental comparison of outcomes in insight and non insight oriented therapy groups</TI>
<SO>Journal of Consulting and Clinical Psychology</SO>
<YR>1972</YR>
<VL>38</VL>
<NO>3</NO>
<PG>411-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rogers-1967" MODIFIED="2008-12-12 10:45:25 +0000" MODIFIED_BY="[Empty name]" NAME="Rogers 1967" YEAR="1967">
<REFERENCE MODIFIED="2008-12-12 10:45:25 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="BOOK">
<AU>Rogers C, Gendlin E, Kiesler DJ, Truax CB</AU>
<SO>The therapeutic relationship and its impact: a study of psychotherapy with schizophrenics</SO>
<YR>1967</YR>
<PG>23-366</PG>
<ED>Rogers C</ED>
<PB>The University of Wisconsin Press</PB>
<CY>Madison, Milwaukee, and London</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rohriht-2001" MODIFIED="2009-11-30 13:30:29 +0000" MODIFIED_BY="[Empty name]" NAME="Rohriht 2001" YEAR="2001">
<REFERENCE MODIFIED="2009-11-30 13:30:29 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Rohriht F</AU>
<TI>RCT in effectiveness of body oriented psychotherapy on anergia in patients with chronic schizophrenia</TI>
<SO>National Research Register</SO>
<YR>2001</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rubins-1974" NAME="Rubins 1974" YEAR="1974">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Rubins J, Rucker M</AU>
<TI>On evaluating the effectiveness of psychoanalytic therapy for the acute schizophrenias</TI>
<SO>American Journal of Psychoanalysis</SO>
<YR>1974</YR>
<VL>34</VL>
<NO>3</NO>
<PG>241-56</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schachter-2001" NAME="Schachter 2001" YEAR="2001">
<REFERENCE PRIMARY="YES" TYPE="OTHER">
<AU>Schachter J</AU>
<TI>Multi-centre study: the effectiveness of psychodynamic psychotherapy: an ongoing evaluation of treatment</TI>
<SO>National Research Register</SO>
<YR>2001</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schneider-1993" NAME="Schneider 1993" YEAR="1993">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Schneider L</AU>
<TI>Efficacy of treatment for geropsychiatric patients with severe mental illness</TI>
<SO>Psychopharmacology Bulletin</SO>
<YR>1993</YR>
<VL>29</VL>
<NO>4</NO>
<PG>501-24</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Scott-1995" NAME="Scott 1995" YEAR="1995">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Scott JE, Dixon LB</AU>
<TI>Psychological interventions for schizophrenia</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>1995</YR>
<VL>21</VL>
<NO>4</NO>
<PG>621-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Silverman-1978" MODIFIED="2009-03-03 08:44:21 +0000" MODIFIED_BY="[Empty name]" NAME="Silverman 1978" YEAR="1978">
<REFERENCE MODIFIED="2009-03-03 08:44:21 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Silverman LH</AU>
<TI>Unconscious symbiotic fantasy: A ubiquitous therapeutic agent</TI>
<SO>International Journal of Psychoanalytic Psychotherapy</SO>
<YR>1978</YR>
<VL>79</VL>
<NO>7</NO>
<PG>562-85</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1919"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sines-1961" NAME="Sines 1961" YEAR="1961">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Sines LK, Silver RJ, Lucero RJ</AU>
<TI>The effect of therapeutic intervention by untrained therapists</TI>
<SO>Journal of Clinical Psychology</SO>
<YR>1961</YR>
<VL>17</VL>
<NO>4</NO>
<PG>394-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sjostrom-1990" NAME="Sjostrom 1990" YEAR="1990">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Sjostrom R</AU>
<TI>Psychotherapy in schizophrenia: a prospective study</TI>
<TO>Psykoterapi vid schizofreni: en prospektiv studie</TO>
<SO>Läkartidningen</SO>
<YR>1990</YR>
<VL>87</VL>
<PG>3279-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stevens-1973" NAME="Stevens 1973" YEAR="1973">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Stevens BC</AU>
<TI>Evaluation of rehabilitation for psychotic patients in the community</TI>
<SO>Acta Psychiatrica Scandinavica</SO>
<YR>1973</YR>
<VL>49</VL>
<PG>169-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sverdlov-1980" NAME="Sverdlov 1980" YEAR="1980">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Sverdlov L</AU>
<TI>Clinico-psychopathological and clinico-psychological analyses of the process of formation of therapeutic remission in acute schizophrenic psychoses</TI>
<SO>Trudy Leningradskogo Nauchno Issledovatel'skogo Psikhonevrologicheskogo Instituta im VM Bekhtereva</SO>
<YR>1980</YR>
<VL>95</VL>
<PG>48-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tarrier-1999" NAME="Tarrier 1999" YEAR="1999">
<REFERENCE PRIMARY="YES" TYPE="OTHER">
<AU>Tarrier N</AU>
<TI>A psychological intervention programme to reduce positive symptoms and prevent relapse in psychotic patients</TI>
<SO>National Research Register</SO>
<YR>1999</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tienari-1986" NAME="Tienari 1986" YEAR="1986">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Tienari P</AU>
<TI>Psychotherapy research on schizophrenia</TI>
<SO>Psychiatria Fennica</SO>
<YR>1986</YR>
<VL>17</VL>
<PG>127-35</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Volterra-1996" MODIFIED="2009-03-03 08:48:58 +0000" MODIFIED_BY="[Empty name]" NAME="Volterra 1996" YEAR="1996">
<REFERENCE MODIFIED="2009-03-03 08:47:28 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Volterra V, De Ronchi D, Belelli G, Ruggeri M, Borsetti G, Cotani P</AU>
<TI>Effects of psychodynamic therapy in schizophrenic patients</TI>
<SO>Proceeding of the 10th World Congress of Psychiatry;1996 Aug 23-28; Madrid</SO>
<YR>1996</YR>
<CY>Madrid</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-03-03 08:48:58 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="CONFERENCE_PROC">
<AU>Volterra V, de Ronchi D, Belelli G, Ruggeri M, Lunardi A</AU>
<TI>Effects of psychodynamic therapy in schizophrenic patients</TI>
<SO>Proceedings of the 149th Annual Meeting of the American Psychiatric Association;1996 May 4-9; New York</SO>
<YR>1996</YR>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vora-1977" NAME="Vora 1977" YEAR="1977">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Vora S, Layman WA, Mann ET, Danesino A</AU>
<TI>The effects of long-term psychotherapy on patients' self-perception</TI>
<SO>Diseases of the Nervous System</SO>
<YR>1977</YR>
<VL>38</VL>
<NO>9</NO>
<PG>717-21</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="78002963"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Werbart-1988" NAME="Werbart 1988" YEAR="1988">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Werbart A</AU>
<TI>Guidelines for qualitative analysis in clinical evaluation research</TI>
<TO>Riktlinjer för kvalitativ analys vid klinisk utvärderingsforskning</TO>
<SO>Psykisk Hälsa</SO>
<YR>1988</YR>
<VL>29</VL>
<NO>1</NO>
<PG>40-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Young-1979" NAME="Young 1979" YEAR="1979">
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Young RC, Glick ID, Hargreaves WA, Braff D, Drues J</AU>
<TI>Therapist A-B score and treatment outcome with psychiatric in patients: a table of random numbers</TI>
<SO>British Journal of Medical Psychology</SO>
<YR>1979</YR>
<VL>52</VL>
<NO>2</NO>
<PG>119-21</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="80020816"/>
</IDENTIFIERS>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2009-03-02 10:11:36 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Wilner-1985" MODIFIED="2008-12-11 12:00:00 +0000" MODIFIED_BY="[Empty name]" NAME="Wilner 1985" NOTES="&lt;p&gt;Drew still trying to find this one 11-12-2008&lt;/p&gt;" NOTES_MODIFIED="2008-12-11 12:00:00 +0000" NOTES_MODIFIED_BY="[Empty name]" YEAR="1985">
<REFERENCE MODIFIED="2008-12-11 11:59:31 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Drew trying still to obtain this 11-12-2008&lt;/p&gt;" NOTES_MODIFIED="2008-12-11 11:59:31 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Wilner D, Freeman H, Surber M, Goldstein M</AU>
<TI>Success in mental health treatment interventions: a review of 211 random assignment studies</TI>
<SO>Journal of Social Service Research</SO>
<YR>1985</YR>
<VL>8</VL>
<NO>4</NO>
<PG>1-21</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES MODIFIED="2009-08-10 12:48:18 +0100" MODIFIED_BY="[Empty name]"/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2010-02-03 18:48:27 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2010-02-03 18:48:27 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Alanen-1997" NAME="Alanen 1997" TYPE="BOOK">
<AU>Alanen YO</AU>
<SO>Schizophrenia: its origins and need-adapted treatment</SO>
<YR>1997</YR>
<PB>Karnac Books</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Altman-1996" NAME="Altman 1996" TYPE="JOURNAL_ARTICLE">
<AU>Altman DG, Bland JM</AU>
<TI>Detecting skewness from summary information</TI>
<SO>BMJ</SO>
<YR>1996</YR>
<VL>313</VL>
<PG>1200</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1919"/>
<IDENTIFIER TYPE="OTHER" VALUE="IPPP020600"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Begg-1996" MODIFIED="2009-02-06 10:28:55 +0000" MODIFIED_BY="[Empty name]" NAME="Begg 1996" TYPE="JOURNAL_ARTICLE">
<AU>Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF</AU>
<TI>Improving the quality of randomized controlled trials. The CONSORT statement</TI>
<SO>JAMA</SO>
<YR>1996</YR>
<VL>276</VL>
<PG>637-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bland-1997" NAME="Bland 1997" TYPE="JOURNAL_ARTICLE">
<AU>Bland JM</AU>
<TI>Statistics notes. Trials randomised in clusters</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<PG>600</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Boissel-1999" NAME="Boissel 1999" TYPE="JOURNAL_ARTICLE">
<AU>Boissel JP, Cucherat M, Li W, Chatellier G, Gueyffier F, Buyse M, Boutitie F, Nony P, Haugh M, Mignot G</AU>
<TI>The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use</TI>
<SO>Therapie</SO>
<YR>1999</YR>
<VL>54</VL>
<NO>4</NO>
<PG>405-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Carpenter-1994" NAME="Carpenter 1994" TYPE="JOURNAL_ARTICLE">
<AU>Carpenter WT Jr, Buchanan RW</AU>
<TI>Schizophrenia</TI>
<SO>New England Journal of Medicine</SO>
<YR>1994</YR>
<VL>330</VL>
<PG>681-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chalmers-1983" MODIFIED="2008-12-12 10:52:45 +0000" MODIFIED_BY="[Empty name]" NAME="Chalmers 1983" TYPE="JOURNAL_ARTICLE">
<AU>Chalmers TC, Celano P, Sacks HS, Smith H Jr</AU>
<TI>Bias in treatment assignment in controlled clinical trials</TI>
<SO>New England Journal of Medicine</SO>
<YR>1983</YR>
<VL>309</VL>
<PG>1358-61</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Deeks-2000" MODIFIED="2009-03-03 08:52:18 +0000" MODIFIED_BY="[Empty name]" NAME="Deeks 2000" TYPE="CONFERENCE_PROC">
<AU>Deeks J</AU>
<TI>Issues in the selection for meta-analyses of binary data</TI>
<SO>Proceeding of the 8th International Cochrane Colloquium; 2000 Oct 25-28th; Cape Town, South Africa</SO>
<YR>2000</YR>
<CY>Cape Town</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Divine-1992" NAME="Divine 1992" TYPE="JOURNAL_ARTICLE">
<AU>Divine GW, Brown JT, Frazier LM</AU>
<TI>The unit of analysis error in studies about physicians' patient care behavior</TI>
<SO>Journal of General Internal Medicine</SO>
<YR>1992</YR>
<VL>7</VL>
<NO>6</NO>
<PG>623-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Donner-2002" NAME="Donner 2002" TYPE="JOURNAL_ARTICLE">
<AU>Donner A, Klar N</AU>
<TI>Issues in the meta-analysis of cluster randomized trials</TI>
<SO>Statistics in Medicine</SO>
<YR>2002</YR>
<VL>21</VL>
<PG>2971-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Duggan-2005" MODIFIED="2009-03-03 08:53:52 +0000" MODIFIED_BY="[Empty name]" NAME="Duggan 2005" TYPE="COCHRANE_REVIEW">
<AU>Duggan L, Fenton M, Rathbone J, Dardennes R, El-Dosoky A, Indran S</AU>
<TI>Olanzapine for schizophrenia</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>2</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS MODIFIED="2009-03-03 08:53:52 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-03-03 08:53:52 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001359.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" MODIFIED="2009-07-29 10:09:58 +0100" MODIFIED_BY="[Empty name]" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Davey Smith G, Schneider M, Minder C</AU>
<TI>Bias in meta-analysis detected by a simple, graphical test</TI>
<SO>BMJ</SO>
<YR>1997</YR>
<VL>315</VL>
<NO>7109</NO>
<PG>629-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Elbourne-2002" MODIFIED="2009-07-29 10:18:08 +0100" MODIFIED_BY="[Empty name]" NAME="Elbourne 2002" TYPE="JOURNAL_ARTICLE">
<AU>Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A</AU>
<TI>Meta-analyses involving cross-over trials:Sulpiride versus placebo for schizophrenia18 / 22methodological issues</TI>
<SO>International journal of epidemiology</SO>
<YR>2002</YR>
<VL>31</VL>
<NO>1</NO>
<PG>140-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Essali-2009" MODIFIED="2009-03-03 08:54:11 +0000" MODIFIED_BY="[Empty name]" NAME="Essali 2009" TYPE="COCHRANE_REVIEW">
<AU>Essali A, Al-Haj Haasan N, Li C, Rathbone J</AU>
<TI>Clozapine versus 'typical' neuroleptic medication for schizophrenia</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2009</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2009-02-06 10:26:39 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-02-06 10:26:39 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Fenton-1995" NAME="Fenton 1995" TYPE="BOOK_SECTION">
<AU>Fenton WS, McGlashan TH</AU>
<TI>Schizophrenia: individual psychotherapy</TI>
<SO>Comprehensive textbook of psychiatry</SO>
<YR>1995</YR>
<ED>Kaplan H, Sadock B</ED>
<PB>Williams and Wilkins</PB>
<CY>Baltimore, MD</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gulliford-1999" MODIFIED="2009-03-03 08:54:30 +0000" MODIFIED_BY="[Empty name]" NAME="Gulliford 1999" TYPE="JOURNAL_ARTICLE">
<AU>Gulliford MC</AU>
<TI>Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994</TI>
<SO>American Journal of Epidemiology</SO>
<YR>1999</YR>
<VL>149</VL>
<PG>876-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2003" NAME="Higgins 2003" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JP, Thompson SG, Deeks JJ, Altman DG</AU>
<TI>Measuring inconsistency in meta-analyses</TI>
<SO>BMJ</SO>
<YR>2003</YR>
<VL>327</VL>
<PG>557-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008" MODIFIED="2009-03-03 08:56:19 +0000" MODIFIED_BY="[Empty name]" NAME="Higgins 2008" TYPE="OTHER">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions 5.0.1 [updated September 2008]</TI>
<SO>The Cochrane Collaboration</SO>
<YR>2008</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hunter-2003" MODIFIED="2009-02-06 10:47:14 +0000" MODIFIED_BY="[Empty name]" NAME="Hunter 2003" TYPE="COCHRANE_REVIEW">
<AU>Hunter R, Kennedy E, Song F, Gadon L, Irving CB</AU>
<TI>Risperidone versus typical antipsychotic medication for schizophrenia</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2003</YR>
<NO>2</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS MODIFIED="2009-02-06 10:47:14 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-02-06 10:47:14 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE=" 10.1002/14651858"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Jones-1999" MODIFIED="2009-03-02 10:24:00 +0000" MODIFIED_BY="[Empty name]" NAME="Jones 1999" TYPE="COCHRANE_REVIEW">
<AU>Jones C, Cormac I, Mota J, Campbell C</AU>
<TI>Cognitive behaviour therapy for schizophrenia</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>1999</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2009-03-02 10:24:00 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-03-02 10:24:00 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE=" 10.1002/14651858"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Jones-2004" MODIFIED="2009-02-06 10:51:11 +0000" MODIFIED_BY="[Empty name]" NAME="Jones 2004" TYPE="COCHRANE_REVIEW">
<AU>Jones C, Cormac I, Silveira da Mota Neto JI, Campbell C</AU>
<TI>Cognitive behaviour therapy for schizophrenia</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2004</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2009-02-06 10:51:11 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-02-06 10:51:11 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE=" 10.1002/14651858"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-J_x00fc_ni-2001" MODIFIED="2010-02-03 18:37:24 +0000" MODIFIED_BY="[Empty name]" NAME="Jüni 2001" TYPE="JOURNAL_ARTICLE">
<AU>Jüni P, Altman DG, Egger M</AU>
<TI>Systematic reviews in health care: Assessing the quality of controlled clinical trials</TI>
<SO>BMJ</SO>
<YR>2001</YR>
<VL>323</VL>
<PG>42-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kay-1986" NAME="Kay 1986" TYPE="BOOK">
<AU>Kay SR, Opler LA, Fiszbein A</AU>
<SO>Positive and negative syndrome scale (PANSS) manual</SO>
<YR>1986</YR>
<PB>Multi-Health Systems</PB>
<CY>North Tonawanda (NY)</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lawrie-1998" NAME="Lawrie 1998" TYPE="JOURNAL_ARTICLE">
<AU>Lawrie SM, Abukmeil SS</AU>
<TI>Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies</TI>
<SO>British Journal of Psychiatry</SO>
<YR>1998</YR>
<VL>172</VL>
<PG>110-20</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1919"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Leucht-2005a" NAME="Leucht 2005a" TYPE="JOURNAL_ARTICLE">
<AU>Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R</AU>
<TI>Clinical implications of Brief Psychiatric Rating Scale Scores</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2005</YR>
<VL>187</VL>
<PG>366-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Leucht-2005b" NAME="Leucht 2005b" TYPE="JOURNAL_ARTICLE">
<AU>Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R</AU>
<TI>What does the PANSS mean?</TI>
<SO>Schizophrenia Research</SO>
<YR>2005</YR>
<VL>79</VL>
<PG>231-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Luborsky-1962" NAME="Luborsky 1962" TYPE="JOURNAL_ARTICLE">
<AU>Luborsky L</AU>
<TI>Clinicians judgements of mental health: a proposed scale</TI>
<SO>Archives of General Psychiatry</SO>
<YR>1962</YR>
<VL>7</VL>
<PG>407-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Malmberg-2001" MODIFIED="2010-02-03 18:48:27 +0000" MODIFIED_BY="[Empty name]" NAME="Malmberg 2001" TYPE="COCHRANE_REVIEW">
<AU>Malmberg L, Fenton M</AU>
<TI>Individual psychodynamic psychotherapy and psychoanalysis for schizophrenia and severe mental illness</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2001</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2010-02-03 18:48:25 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-02-03 18:48:25 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001360."/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Marshall-2000" NAME="Marshall 2000" TYPE="JOURNAL_ARTICLE">
<AU>Marshall M, Lockwood A, Bradley C, Adams C, Joy C, Fenton M</AU>
<TI>Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia</TI>
<SO>British Journal of Psychiatry</SO>
<YR>2000</YR>
<VL>176</VL>
<PG>249-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-McIntosh-2006" MODIFIED="2009-03-03 08:58:10 +0000" MODIFIED_BY="[Empty name]" NAME="McIntosh 2006" TYPE="COCHRANE_REVIEW">
<AU>McIntosh A, Conlon L, Lawrie S, Stanfield AC</AU>
<TI>Compliance therapy for schizophrenia</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2009-03-03 08:58:10 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-03-03 08:58:10 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Moher-1998" MODIFIED="2008-12-12 10:51:34 +0000" MODIFIED_BY="[Empty name]" NAME="Moher 1998" TYPE="JOURNAL_ARTICLE">
<AU>Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP</AU>
<TI>Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?</TI>
<SO>Lancet</SO>
<YR>1998</YR>
<VL>352</VL>
<PG>609-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moher-2001" MODIFIED="2010-02-03 18:38:22 +0000" MODIFIED_BY="[Empty name]" NAME="Moher 2001" TYPE="JOURNAL_ARTICLE">
<AU>Moher D, Schulz KF, Altman DG</AU>
<TI>The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials</TI>
<SO>Lancet</SO>
<YR>2001</YR>
<VL>357</VL>
<NO>9263</NO>
<PG>1191-94</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Overall-1962" NAME="Overall 1962" TYPE="JOURNAL_ARTICLE">
<AU>Overall JE, Gorham DR</AU>
<TI>The Brief Psychiatric Rating Scale</TI>
<SO>Psychological Reports</SO>
<YR>1962</YR>
<VL>10</VL>
<PG>799-812</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pharoah-2006" MODIFIED="2009-02-06 10:34:27 +0000" MODIFIED_BY="[Empty name]" NAME="Pharoah 2006" TYPE="COCHRANE_REVIEW">
<AU>Pharoah F, Mari J, Rathbone J, Wong W</AU>
<TI>Family intervention for schizophrenia</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2009-02-06 10:34:27 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-02-06 10:34:27 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE=" 10.1002/14651858"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Rust-1989" MODIFIED="2009-07-24 12:40:19 +0100" MODIFIED_BY="[Empty name]" NAME="Rust 1989" TYPE="BOOK">
<AU>Rust J, Golombok S</AU>
<SO>Modern Psychometrics</SO>
<YR>1989</YR>
<PB>Routledge</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sandler-1992" NAME="Sandler 1992" TYPE="JOURNAL_ARTICLE">
<AU>Sandler J</AU>
<TI>Reflections on developments in the theory of psychoanalytic technique</TI>
<SO>International Journal of Psychoanalysis</SO>
<YR>1992</YR>
<VL>73</VL>
<NO>2</NO>
<PG>189-98</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1919"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Schulz-1995" MODIFIED="2008-12-12 10:53:22 +0000" MODIFIED_BY="[Empty name]" NAME="Schulz 1995" TYPE="JOURNAL_ARTICLE">
<AU>Schulz KF, Chalmers I, Hayes RJ, Altman DG</AU>
<TI>Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials</TI>
<SO>JAMA</SO>
<YR>1995</YR>
<VL>273</VL>
<PG>408-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stanton-1984" MODIFIED="2009-03-02 10:16:15 +0000" MODIFIED_BY="[Empty name]" NAME="Stanton 1984" TYPE="JOURNAL_ARTICLE">
<AU>Stanton AH, Gunderson JG, Knapp PH, Frank AF, Vannicelli ML, Schnitzer R, Rosenthal R</AU>
<TI>Effects of psychotherapy in schizophrenia. I. Design and implementation of a controlled study</TI>
<SO>Schizophrenia Bulletin</SO>
<YR>1984</YR>
<VL>10</VL>
<NO>4</NO>
<PG>520-63</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1919"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Thornley-1998" MODIFIED="2009-02-06 10:34:53 +0000" MODIFIED_BY="[Empty name]" NAME="Thornley 1998" TYPE="JOURNAL_ARTICLE">
<AU>Thornley B, Adams CE</AU>
<TI>Content and quality of 2000 controlled trials in schizophrenia over 50 years</TI>
<SO>BMJ</SO>
<YR>1998</YR>
<VL>317</VL>
<PG>1181-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ukoumunne-1999" MODIFIED="2009-02-06 12:31:35 +0000" MODIFIED_BY="[Empty name]" NAME="Ukoumunne 1999" TYPE="JOURNAL_ARTICLE">
<AU>Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC, Burney PGJ</AU>
<TI>Methods for evaluating area-wide and organisation-based intervention in health and health care: a systematic review</TI>
<SO>Health Technology Assessment</SO>
<YR>1999</YR>
<VL>3</VL>
<NO>5</NO>
<PG>1-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Xia-2007" MODIFIED="2010-02-03 18:40:40 +0000" MODIFIED_BY="[Empty name]" NAME="Xia 2007" TYPE="CONFERENCE_PROC">
<AU>Xia J, Adams CE, Bhagat N, Bhagat V, Bhoopathi P, El-Sayeh H, Pinfold V, Takriti Y</AU>
<TI>The Leeds Outcomes Stakeholders Survey (LOSS) Study</TI>
<SO>Proceedings of the 15th Cochrane Colloquium; 2007 Oct 23-27; Sao Paulo</SO>
<YR>2007</YR>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2010-02-03 18:47:30 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Malmberg-1999" MODIFIED="2010-02-03 18:47:30 +0000" MODIFIED_BY="[Empty name]" NAME="Malmberg 1999" TYPE="COCHRANE_REVIEW">
<AU>Malmberg L, Fenton M</AU>
<TI>Individual psychodynamic psychotherapy and psychoanalysis for schizophrenia and severe mental illness</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2001</YR>
<NO>2</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS MODIFIED="2010-02-03 18:47:30 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2010-02-03 18:47:30 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE=" 10.1002/14651858.CD001360."/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2009-11-30 10:41:49 +0000" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2010-02-16 15:15:37 +0000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2010-02-16 15:15:37 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2010-02-16 15:13:49 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gunderson-1984">
<CHAR_METHODS MODIFIED="2009-02-27 11:18:44 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.<BR/>Blindness: open study.<BR/>Duration: two years, had to stay in therapy for six months to be eligible to go on to two year follow up.<BR/>Setting: all hospitalised initially, then in community.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-08-07 12:33:25 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia (DSM II &amp; III) diagnosis confirmed three times.<BR/>N=164 (almost 2000 screened).<BR/>Age:18 to 35 years.<BR/>Sex: not reported.<BR/>Inclusion criteria: minimal prior treatment, no drug or alcohol problems, no organic illnesses, able to function outside of hospital for four consecutive months in some major role without medication in the previous two years.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-02-27 11:19:17 +0000" MODIFIED_BY="[Empty name]">
<P>1. Insight-oriented psychotherapy. N=88*.<BR/>2. Reality-adaptive, supportive psychotherapy. N=76*.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-08-07 12:28:00 +0100" MODIFIED_BY="[Empty name]">
<P>Leaving the study early.<BR/>Global impression: re-hospitalised, unable to take household responsibilities, unable to have key relationship, not self supporting.<BR/>
</P>
<P>Unable to use -<BR/>Mental state: cognition, ego functioning (no SD).<BR/>Signs and symptoms of illness: no SD.<BR/>Use of medication: no SD.<BR/>Hospitalisation: no SD.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-02-16 15:13:49 +0000" MODIFIED_BY="[Empty name]">
<P>*Gunderson reports randomising 95 people. In earlier report of same study (<LINK REF="REF-Stanton-1984" TYPE="REFERENCE">Stanton 1984</LINK>) 164 people were said to have been randomised. For the 69 people that left early there are no other available data other than leaving the study early. There are only usable data of 95 people staying in therapy beyond six months.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-02-16 15:14:30 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Karon-1981">
<CHAR_METHODS MODIFIED="2009-01-30 10:36:12 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.<BR/>Blindness: unclear, 'blind outcome evaluations'.<BR/>Duration: 20 months.<BR/>Setting: inpatients and outpatients.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-02-16 15:14:30 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: mostly schizophrenia.<BR/>N=36.<BR/>Age: not reported.<BR/>Sex: not reported.<BR/>Inclusion criteria: aim to include 'acutely ill, but clearly schizophrenic' participants, first admission.<BR/>Exclusion criteria: no history of ECT, or insulin shock treatment; no organic brain damage; no history of alcoholism, or drug addiction.<BR/>History: it later emerged that about one third of participants had been previously hospitalised; range 7 to 72 days, mean 23.7 days.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-08-07 12:29:30 +0100" MODIFIED_BY="[Empty name]">
<P>1. Psychotherapy without medication. N=12.<BR/>2. Psychotherapy with medication (phenothiazines, typically 400 mg/day chlorpromazine or equivalent). N=12.<BR/>3. Hospital comparison with medication (phenothiazines, typically 400 mg/day chlorpromazine or equivalent). N=12.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-08-07 12:29:36 +0100" MODIFIED_BY="[Empty name]">
<P>Re-hospitalisation.</P>
<P>Unable to use -<BR/>Cognitive functions: WAIS (no usable data).<BR/>Days hospitalised: no SD.<BR/>Leaving the study early: no usable data.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-08-07 12:33:57 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-May-1976">
<CHAR_METHODS MODIFIED="2009-08-07 12:33:07 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.<BR/>Blindness: open study.<BR/>Duration: until discharge or 6 to12 months of treatment.<BR/>Setting: Camarillo State hospital.<BR/>Follow up after discharge (and from assigned interventions) up to five years.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-08-07 12:33:20 +0100" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia, no further details.<BR/>N=228.<BR/>Age: no details.<BR/>Sex: men and women.<BR/>Inclusion criteria: age 16 to 45 years; no evidence of organic brain damage or epilepsy; no major physical illness; no history of alcohol or drug addiction.<BR/>Exclusions: people who were 'obviously not going to be discharged within two years', and those whose illness went into remission during 18-day assessment period.<BR/>History: first admission with no significant prior treatment.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-02-27 11:30:17 +0000" MODIFIED_BY="[Empty name]">
<P>1. Individual psychotherapy. N=46.<BR/>2. Ataraxic drugs (trifluoperazine). N=48.<BR/>3. Individual psychotherapy and ataraxic drugs. N=44.<BR/>4. ECT. N=47.<BR/>5. Milieu therapy and ataraxic drugs. N=43.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-08-07 12:33:57 +0100" MODIFIED_BY="[Empty name]">
<P>Leaving the study early.<BR/>Global impression: discharge from hospital.<BR/>Menninger Health Sickness Scale.<BR/>Medication use after discharge.<BR/>Best level of functioning.<BR/>Usable data available for three years.<BR/>
</P>
<P>Unable to use -<BR/>Relapse: no usable data.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2010-02-16 15:15:37 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-O_x0027_Brien-1972">
<CHAR_METHODS MODIFIED="2009-02-02 11:15:32 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised, no further details.<BR/>Blindness: open study.<BR/>Duration: 20 months.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-02-16 15:15:37 +0000" MODIFIED_BY="[Empty name]">
<P>Diagnosis: schizophrenia, case notes contained clear evidence of a psychotic episode, no further details.<BR/>N=100.<BR/>Age: mean~37 years.<BR/>Sex: 39M, 61F.<BR/>History: newly discharged from acute inpatient care; mean number of hospitalisations ~ 2.9.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-02-27 11:35:41 +0000" MODIFIED_BY="[Empty name]">
<P>1. Individual psychotherapy. N=50.<BR/>2. Group psychotherapy. N=50.</P>
<P>All participants on medication at the start of the study.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-08-07 12:34:17 +0100" MODIFIED_BY="[Empty name]">
<P>Global impression: re-hospitalisation, not improved, discharged, remaining in therapy.</P>
<P>Unable to use -<BR/>Mental state: BPRS (no usable data), Zung Self Rating Scale (no data).<BR/>Mental status: Mental Status Scale (no usable data).<BR/>Social functioning: Social Effectiveness Scale (no usable data).<BR/>Leaving the study early: no data.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-08-07 12:34:27 +0100" MODIFIED_BY="[Empty name]">
<P>Dropped 13 participants from analysis, but it was clear from which groups, so they were added back in in an effort to undertake an intention-to-treat analysis.<BR/>No details of orientation or frequency of sessions.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>BPRS: Brief Psychiatric Rating Scale<BR/>DCS: Discrimination Criteria for Schizophrenia<BR/>DSM II &amp; III: Diagnostic and Statistical Manual of Mental Disorders<BR/>ECT: electroconvulsive therapy<BR/>EIO: insight-oriented psychotherapy<BR/>MHSS: Menninger Health Sickness Scale<BR/>RAS: reality-adaptive supportive psychotherapy<BR/>
<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2010-02-15 15:59:01 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Appelbaum-1986">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, description of organisation of psychotherapy wards.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-07 12:35:21 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Armstrong-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-07 12:35:21 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: unclear.<BR/>Interventions: life skills programme in day hospital versus supportive psychotherapeutic milieu in day hospital; not psychoanalytic or psychodynamic therapy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-07 12:35:32 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Azima-1959">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-07 12:35:32 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: unclear.<BR/>Methods: drugs given and observations collected using a double-blind method, likely A-B-C-A crossover trial.<BR/>Interventions: phenobarbital or reserpine, not psychodynamic therapy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Bellak-1973">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, case report.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cancro-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-30 10:42:43 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Carpenter-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-30 10:42:43 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised, review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Carpenter-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-02 10:30:22 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chiesa-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-02 10:30:22 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: random.<BR/>Participants: not people with schizophrenia.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Chodoff-1982">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Cormier-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, before and after study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-De-Socarraz-1978">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: random.<BR/>Participants: neurotic patients, not people with schizophrenia.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-30 10:42:18 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Docherty-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-30 10:42:18 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised, review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Dyrud-1973">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Epstein-1981">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-02 10:31:05 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Falloon-1983">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-02 10:31:05 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: random.<BR/>Participants: people with schizophrenia.<BR/>Intervention: family therapy and supportive individual therapy, not psychodynamic therapy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Friedman-1973">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gabbard-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gillieron-1980">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, survey and factorial analysis of a questionnaire.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-02 10:31:37 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Glick-1974">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-02 10:31:37 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: people with schizophrenia. <BR/>Interventions: short versus long hospitalisation, not psychoanalytic therapy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-02 10:31:48 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Green-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-02 10:31:48 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: people with schizophrenia.<BR/>Interventions: type of psychotherapy, no further details (author contacted, no reply).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-02 10:32:23 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Guthrie-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-02 10:32:23 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: random.<BR/>Participants: people without psychosis (personal communication from Dr Guthrie).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Harding-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-15 15:59:01 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hogarty-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-15 15:59:01 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: random, no further details.<BR/>Participants: people with schizophrenia or schizoaffective disorder. N=186.<BR/>Interventions: personal therapy, family psycho-education, combined personal therapy and family psycho-education or supportive therapy. Personal therapy seemed to have a definition akin to cognitive behavioural therapy. "Through a process called 'internal coping', personal therapy encouraged the patient to identify the affective, cognitive and physiological experience of stress."</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-03-02 11:18:13 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Jones-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-03-02 11:18:13 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: people with auditory hallucinations.<BR/>Interventions: cognitive behavioural therapy versus standard care, not psychodynamic therapy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kaplan-1985">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-07 12:37:03 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Karon-1969">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-07 12:37:03 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: people with schizophrenia.<BR/>Interventions: psychoanalytic individual therapy versus ego analytic therapy versus supportive psychotherapy versus medication.<BR/>Outcomes: psychological tests (Thorndyke Gallup Vocabulary, Porteus Mazes, WAIS IQ test, VVT), use of medication (no usable data).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Karon-1984">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Klerman-1984">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Krull-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-07 12:37:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lindberg-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-07 12:37:14 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: non randomised, matched pairs retrospective study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Luborsky-1975">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-02 10:33:14 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Matthews-1981">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-02 10:33:14 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: people with schizophrenia.<BR/>Interventions: practitioners 'A' versus practitioners 'B' (according to level of experience in psychotherapy).<BR/>Outcomes: no usable data.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Matussek-1974">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, cohort study.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-30 10:42:27 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-May-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-30 10:42:27 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised, review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mueser-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, review and editorial.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Muller-1978">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-30 10:42:29 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Muller-1984">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-30 10:42:29 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised, review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Res.-committee-1975">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Resch-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-01-09 18:14:50 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Roback-1972">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-01-09 18:14:50 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: men, n=24 (20 diagnosed with schizophrenia).<BR/>Interventions: interpretive group therapy versus interactive group therapy.<BR/>Outcomes: self rating of insight, psychometric tests (no usable data).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-02 10:34:49 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rogers-1967">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-02 10:34:49 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: people with schizophrenia, with people without schizophrenia as controls.<BR/>Interventions: therapeutic relationships, no psychodynamic therapy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-02-15 15:58:31 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rohriht-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-02-15 15:58:31 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: people with schizophrenia.<BR/>Interventions: body-oriented psychotherapeutic intervention versus standard care; body-oriented psychotherapy have as their primary principle to overcome communication barriers through the introduction of non-verbal techniques; not psychoanalytic or psychodynamic therapy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Rubins-1974">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-27 11:45:45 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schachter-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-27 11:45:45 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: random.<BR/>Participants: unclear if schizophrenia.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Schneider-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Scott-1995">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Silverman-1978">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2010-01-09 18:15:21 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sines-1961">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2010-01-09 18:15:21 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: participants allocated to 'psychiatric aides'.<BR/>Participants: 40 people with schizophrenia, 7 "mental defectives" and 13 other diagnoses.<BR/>Interventions: twice weekly meetings of 50 minutes for the purpose of 'improving the patients psychiatric and behavioural status'; during the 50 minutes, aides engaged in various activities, none of which resembled psychodynamic therapy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-02 10:38:09 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sjostrom-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-02 10:38:09 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: people with schizophrenia.<BR/>Intervention: psychotherapy with dynamic elements versus standard care.<BR/>Outcomes: no usable data.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-02 10:38:46 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stevens-1973">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-02 10:38:46 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-02 10:38:56 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sverdlov-1980">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-02 10:38:56 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-02 10:39:18 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tarrier-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-02 10:39:18 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: people with chronic schizophrenia suffering residual psychotic symptoms.<BR/>Interventions: cognitive behavorial psychotherapy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-02 10:39:22 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tienari-1986">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-02 10:39:22 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: not randomised, review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-07 12:38:22 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Volterra-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-07 12:38:22 +0100" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: people with schizophrenia.<BR/>Intervention: group and individual psychotherapy (plus haloperidol 2 mg/day) versus drug treatment alone.<BR/>Outcome: no data available (Congress abstract).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Vora-1977">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: randomised.<BR/>Participants: clinic attenders who received therapy in excess of one year, 53% neurotic, 47% either psychotic or characterological disorders, data not presented for people with schizophrenia alone.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Werbart-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Allocation: not randomised, review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-02-02 10:40:59 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Young-1979">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-02-02 10:40:59 +0000" MODIFIED_BY="[Empty name]">
<P>Allocation: randomised.<BR/>Participants: people with schizophrenia (n=141) and 94 with other diagnoses.<BR/>Interventions: long versus short hospitalisation and therapists A-B-scores, not psychodynamic psychotherapy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2009-08-07 12:39:01 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2009-08-07 12:39:01 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wilner-1985">
<CHAR_METHODS MODIFIED="2009-02-27 11:50:20 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-08-07 12:38:50 +0100" MODIFIED_BY="[Empty name]">
<P>Unknown</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-08-07 12:38:54 +0100" MODIFIED_BY="[Empty name]">
<P>Unknown</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-08-07 12:39:01 +0100" MODIFIED_BY="[Empty name]">
<P>Unknown</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2009-08-10 12:48:18 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2009-02-27 11:37:18 +0000" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2009-02-27 11:37:03 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-27 11:20:34 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gunderson-1984">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-27 11:28:22 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Karon-1981">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-27 11:31:01 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-May-1976">
<DESCRIPTION>
<P>Randomised, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-27 11:37:03 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-O_x0027_Brien-1972">
<DESCRIPTION>
<P>Random, no further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2009-02-27 11:37:06 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-27 11:20:36 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gunderson-1984">
<DESCRIPTION>
<P>No further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-27 11:28:25 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Karon-1981">
<DESCRIPTION>
<P>No further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-27 11:31:03 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-May-1976">
<DESCRIPTION>
<P>No further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-27 11:37:06 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-O_x0027_Brien-1972">
<DESCRIPTION>
<P>No further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2009-02-27 11:37:09 +0000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-02-27 11:20:37 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gunderson-1984">
<DESCRIPTION>
<P>Open study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-02-05 16:02:32 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Karon-1981">
<DESCRIPTION>
<P>Not reported for therapists or participants, probably open design.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-02-27 11:31:05 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-May-1976">
<DESCRIPTION>
<P>Open study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-02-27 11:37:09 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-O_x0027_Brien-1972">
<DESCRIPTION>
<P>Open study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2009-02-27 11:37:13 +0000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-02-27 11:20:40 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gunderson-1984">
<DESCRIPTION>
<P>Numbers randomised were not clearly reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-02-27 11:28:43 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Karon-1981">
<DESCRIPTION>
<P>Study attrition not clearly reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-02-27 11:31:09 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-May-1976">
<DESCRIPTION>
<P>Study attrition not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-02-27 11:37:13 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-O_x0027_Brien-1972">
<DESCRIPTION>
<P>Study attrition not adequately reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2009-02-27 11:37:16 +0000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-27 11:20:43 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gunderson-1984">
<DESCRIPTION>
<P>No further details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-27 11:28:48 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Karon-1981">
<DESCRIPTION>
<P>No details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-27 11:31:12 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-May-1976">
<DESCRIPTION>
<P>No details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-27 11:37:16 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-O_x0027_Brien-1972">
<DESCRIPTION>
<P>No details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2009-02-27 11:37:18 +0000" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-27 11:20:48 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gunderson-1984">
<DESCRIPTION>
<P>No details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-27 11:28:50 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Karon-1981">
<DESCRIPTION>
<P>No details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-27 11:31:13 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-May-1976">
<DESCRIPTION>
<P>No details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-02-27 11:37:18 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-O_x0027_Brien-1972">
<DESCRIPTION>
<P>No details.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2010-01-11 12:19:25 +0000" MODIFIED_BY="[Empty name]">
<SOF_TABLE ID="SOF-01" MODIFIED="2010-01-11 12:19:25 +0000" MODIFIED_BY="Grade Profiler" NO="1" READONLY="YES">
<TITLE MODIFIED="2010-01-11 12:19:25 +0000" MODIFIED_BY="Grade Profiler">INDIVIDUAL PSYCHODYNAMIC PSYCHOTHERAPY versus MEDICATION for schizophrenia and severe mental illness</TITLE>
<TABLE COLS="7" ROWS="6">
<TR>
<TD COLSPAN="7">
<P>
<B>INDIVIDUAL PSYCHODYNAMIC PSYCHOTHERAPY versus MEDICATION for schizophrenia and severe mental illness</B>
</P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>
<B>Patient or population:</B> patients with schizophrenia and severe mental illness<BR/>
<B>Settings:</B> in hospital<BR/>
<B>Intervention:</B> INDIVIDUAL PSYCHODYNAMIC PSYCHOTHERAPY versus MEDICATION<BR/>
</P>
</TD>
</TR>
<TR>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Outcomes</P>
</TH>
<TH ALIGN="LEFT" COLSPAN="2" VALIGN="TOP">
<P>Illustrative comparative risks* (95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Relative effect<BR/>(95% CI)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>No of Participants<BR/>(studies)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Quality of the evidence<BR/>(GRADE)</P>
</TH>
<TH ALIGN="LEFT" ROWSPAN="3" VALIGN="TOP">
<P>Comments</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Assumed risk</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Corresponding risk</P>
</TH>
</TR>
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>Control</B>
</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>
<B>INDIVIDUAL PSYCHODYNAMIC PSYCHOTHERAPY versus MEDICATION</B>
</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Committed suicide by three years</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>42 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>22 per 1000</B>
<BR/>(2 to 234)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.52 </B>
<BR/>(0.05 to 5.56)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>94<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>1,2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Global impression: 1. Not able to be discharged (long term)</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>42 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>351 per 1000</B>
<BR/>(85 to 1000)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 8.35 </B>
<BR/>(2.03 to 34.3)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>94<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>1,2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Global impression: 2. Given medication during 12 months to three years follow up - by 12 months</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>958 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>613 per 1000</B>
<BR/>(479 to 776)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.64 </B>
<BR/>(0.5 to 0.81)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>94<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>1,2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>Global impression: 2. Given medication during 12 months to three years follow up - by three years</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>1000 per 1000</B>
</P>
</TD>
<TD ROWSPAN="1" VALIGN="TOP">
<P>
<B>850 per 1000</B>
<BR/>(750 to 960)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>
<B>RR 0.85 </B>
<BR/>(0.75 to 0.96)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>94<BR/>(1 study)</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P>&#8853;&#8853;&#8861;&#8861;<BR/>
<B>low</B>
<SUP>1,2</SUP>
</P>
</TD>
<TD ALIGN="LEFT" ROWSPAN="1" VALIGN="TOP">
<P/>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>*The basis for the <B>assumed risk</B> (e.g. the median control group risk across studies) is provided in footnotes. The <B>corresponding risk</B> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <B>relative effect</B> of the intervention (and its 95% CI).<BR/>
<B>CI:</B> Confidence interval; <B>RR:</B> Risk ratio; </P>
</TD>
</TR>
<TR>
<TD COLSPAN="7">
<P>GRADE Working Group grades of evidence<BR/>
<B>High quality:</B> Further research is very unlikely to change our confidence in the estimate of effect. <BR/>
<B>Moderate quality:</B> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<BR/>
<B>Low quality:</B> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<BR/>
<B>Very low quality:</B> We are very uncertain about the estimate.<BR/>
</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>1</SUP> Randomisation undertaken but not clearly described. <BR/>
<SUP>2</SUP> One small single study.</P>
</FOOTNOTES>
</SOF_TABLE>
</SOF_TABLES>
<ADDITIONAL_TABLES MODIFIED="2010-02-16 15:26:41 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2010-02-16 15:26:41 +0000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2010-02-16 15:26:31 +0000" MODIFIED_BY="[Empty name]">. Suggested design of study</TITLE>
<TABLE COLS="2" ROWS="5">
<TR>
<TH>
<P>Methods</P>
</TH>
<TD>
<P>Allocation: randomised, block, fully explicit description.<BR/>Blinding: single, tested.<BR/>Duration: 12 weeks treatment, and then follow up to at least 26 weeks.</P>
</TD>
</TR>
<TR>
<TH>
<P>Participants</P>
</TH>
<TD>
<P>Diagnosis: schizophrenia (ICD).<BR/>N=300.*<BR/>Age: adults.<BR/>Sex: both.<BR/>
</P>
</TD>
</TR>
<TR>
<TH>
<P>Interventions</P>
</TH>
<TD>
<P>1. Individual Psychodynamic Psychotherapy. N=150.<BR/>
</P>
<P>2. Standard care. N=150.</P>
</TD>
</TR>
<TR>
<TH>
<P>Outcomes</P>
</TH>
<TD>
<P>General: time to all-cause treatment failure marked by its discontinuation, relapse, general impression of clinician (CGI), career/other (CGI), compliance with treatment., healthy days,<BR/>Mental state: CGI.<BR/>Quality of life. CGI.<BR/>Family burden: CGI.<BR/>Social functioning: return to everyday living for 80% of time.*<BR/>Adverse events: any adverse event recorded.<BR/>Economic outcomes.</P>
</TD>
</TR>
<TR>
<TH>
<P>Notes</P>
</TH>
<TD>
<P>* Powered to be able to identify a difference of ~20% between groups for primary outcome with adequate degree of certainty.</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES/>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2010-02-16 15:05:51 +0000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2010-01-10 11:38:07 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>INDIVIDUAL PSYCHODYNAMIC PSYCHOTHERAPY versus MEDICATION</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="5.5597805557912" CI_START="0.04896087489339862" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5217391304347826" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.7450576503428933" LOG_CI_START="-1.3101508302828293" LOG_EFFECT_SIZE="-0.28254658996996806" METHOD="MH" MODIFIED="2010-01-10 11:29:52 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="0.0" P_Z="0.5899523575061506" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="46" TOTAL_2="48" WEIGHT="100.0" Z="0.5389050750969469">
<NAME>Committed suicide by three years</NAME>
<GROUP_LABEL_1>IPPP</GROUP_LABEL_1>
<GROUP_LABEL_2>Medication</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours IPPP</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours medication</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.559780555791196" CI_START="0.04896087489339864" EFFECT_SIZE="0.5217391304347826" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.745057650342893" LOG_CI_START="-1.310150830282829" LOG_EFFECT_SIZE="-0.28254658996996806" ORDER="1" O_E="0.0" SE="1.2072396349656036" STUDY_ID="STD-May-1976" TOTAL_1="46" TOTAL_2="48" VAR="1.457427536231884" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="34.30368572570564" CI_START="2.031449358978126" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="8.347826086956522" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="1.5353407848923446" LOG_CI_START="0.3078060004795688" LOG_EFFECT_SIZE="0.9215733926859567" METHOD="MH" MODIFIED="2010-01-10 11:38:07 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="0.0" P_Z="0.003251626700544473" Q="0.0" RANDOM="NO" SCALE="110.26013089671272" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="46" TOTAL_2="48" WEIGHT="100.0" Z="2.942891202287082">
<NAME>Global impression: 1. Not able to be discharged (long term)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="34.30368572570564" CI_START="2.0314493589781266" EFFECT_SIZE="8.347826086956522" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="2" LOG_CI_END="1.5353407848923446" LOG_CI_START="0.3078060004795689" LOG_EFFECT_SIZE="0.9215733926859567" ORDER="2" O_E="0.0" SE="0.721060008759246" STUDY_ID="STD-May-1976" TOTAL_1="46" TOTAL_2="48" VAR="0.519927536231884" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.73497109819287" CI_END="0.8469155958304189" CI_START="0.6553119690418254" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.744979145154992" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="94" I2="82.56312049567072" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="-0.0721598695885751" LOG_CI_START="-0.18355189973599084" LOG_EFFECT_SIZE="-0.12785588466228298" METHOD="MH" MODIFIED="2009-08-07 12:42:44 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.016630369778510845" P_Q="0.0" P_Z="6.817845980143676E-6" Q="0.0" RANDOM="NO" SCALE="2.23" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="92" TOTAL_2="96" WEIGHT="200.0" Z="4.499297280387978">
<NAME>Global impression: 2. Given medication during 12 months to three years follow up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.8067139395578264" CI_START="0.5000894001057804" DF="0" EFFECT_SIZE="0.6351606805293005" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="46" I2="0.0" ID="CMP-001.03.01" LOG_CI_END="-0.09328043863068147" LOG_CI_START="-0.3009523506600019" LOG_EFFECT_SIZE="-0.19711639464534172" NO="1" P_CHI2="1.0" P_Z="1.9868199580787467E-4" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="48" WEIGHT="100.0" Z="3.7206864471176786">
<NAME>by 12 months</NAME>
<DICH_DATA CI_END="0.8067139395578264" CI_START="0.5000894001057804" EFFECT_SIZE="0.6351606805293005" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="46" LOG_CI_END="-0.09328043863068147" LOG_CI_START="-0.3009523506600019" LOG_EFFECT_SIZE="-0.19711639464534172" ORDER="3" O_E="0.0" SE="0.12198750911856665" STUDY_ID="STD-May-1976" TOTAL_1="46" TOTAL_2="48" VAR="0.01488095238095238" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9648210825721829" CI_START="0.7472404502363199" DF="0" EFFECT_SIZE="0.8490897126562843" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="48" I2="0.0" ID="CMP-001.03.02" LOG_CI_END="-0.015553215211462256" LOG_CI_START="-0.1265396265545521" LOG_EFFECT_SIZE="-0.07104642088300721" MODIFIED="2009-08-07 12:42:44 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.012097486234237839" STUDIES="1" TAU2="0.0" TOTAL_1="46" TOTAL_2="48" WEIGHT="100.00000000000001" Z="2.5092878394042843">
<NAME>by three years</NAME>
<DICH_DATA CI_END="0.9648210825721829" CI_START="0.7472404502363199" EFFECT_SIZE="0.8490897126562843" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="48" LOG_CI_END="-0.015553215211462256" LOG_CI_START="-0.1265396265545521" LOG_EFFECT_SIZE="-0.07104642088300721" ORDER="4" O_E="0.0" SE="0.06519396741452761" STUDY_ID="STD-May-1976" TOTAL_1="46" TOTAL_2="48" VAR="0.004250253387246487" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="9.991419008728027" CI_START="1.6085809912719826" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="5.800000000000004" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.04" MODIFIED="2009-02-06 11:26:42 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.0066846696877769325" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="46" TOTAL_2="46" UNITS="" WEIGHT="100.0" Z="2.7121581227409015">
<NAME>Global impression: 3. Achieved best level of health MHSS - long term (high=good)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="9.991419008728027" CI_START="1.6085809912719826" EFFECT_SIZE="5.800000000000004" ESTIMABLE="YES" MEAN_1="-40.8" MEAN_2="-46.6" MODIFIED="2009-02-04 10:15:06 +0000" MODIFIED_BY="[Empty name]" ORDER="5" SD_1="9.9" SD_2="10.6" SE="2.13851838186283" STUDY_ID="STD-May-1976" TOTAL_1="46" TOTAL_2="46" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="118.81168669582165" CI_START="2.2537226975563107" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="16.363636363636363" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="2.0748591613343943" LOG_CI_START="0.35290047855576806" LOG_EFFECT_SIZE="1.213879819945081" METHOD="MH" MODIFIED="2009-02-06 11:26:51 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Q="0.0" P_Z="0.005721678462653107" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="44" TOTAL_2="48" WEIGHT="100.0" Z="2.763319181170142">
<NAME>Global impression: 4. Treatment not considered successful by treatment team (long term)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="118.81168669582165" CI_START="2.2537226975563107" EFFECT_SIZE="16.363636363636363" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="1" LOG_CI_END="2.0748591613343943" LOG_CI_START="0.35290047855576806" LOG_EFFECT_SIZE="1.213879819945081" ORDER="6" O_E="0.0" SE="1.0114870540971153" STUDY_ID="STD-May-1976" TOTAL_1="44" TOTAL_2="48" VAR="1.0231060606060607" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.3632724422979847" CI_START="0.286534802494465" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="0.1345826558075669" LOG_CI_START="-0.5428226211194165" LOG_EFFECT_SIZE="-0.2041199826559248" METHOD="MH" MODIFIED="2009-02-27 13:03:48 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Q="0.0" P_Z="0.23753238065441806" Q="0.0" RANDOM="NO" SCALE="14.38772860278799" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="12" TOTAL_2="12" WEIGHT="100.0" Z="1.1811771421251442">
<NAME>Global impression: 5. Hospital re-admission (long term)</NAME>
<GROUP_LABEL_1>Psychodynamic therapy</GROUP_LABEL_1>
<GROUP_LABEL_2>Medication alone</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.363272442297985" CI_START="0.28653480249446495" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="8" LOG_CI_END="0.13458265580756698" LOG_CI_START="-0.5428226211194166" LOG_EFFECT_SIZE="-0.2041199826559248" MODIFIED="2009-01-30 14:54:41 +0000" MODIFIED_BY="[Empty name]" ORDER="30" O_E="0.0" SE="0.3979112128771108" STUDY_ID="STD-Karon-1981" TOTAL_1="12" TOTAL_2="12" VAR="0.15833333333333338" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="3.9280758023929168" CI_START="0.27719599510886866" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0434782608695652" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="0.5941798600322524" LOG_CI_START="-0.5572130486442262" LOG_EFFECT_SIZE="0.018483405694013133" METHOD="MH" MODIFIED="2009-02-06 11:22:27 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Q="0.0" P_Z="0.9498246916949243" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="46" TOTAL_2="48" WEIGHT="100.0" Z="0.06292692824302848">
<NAME>Leaving the study early (long term)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.9280758023929168" CI_START="0.27719599510886866" EFFECT_SIZE="1.0434782608695652" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.5941798600322524" LOG_CI_START="-0.5572130486442262" LOG_EFFECT_SIZE="0.018483405694013133" MODIFIED="2009-02-06 09:48:36 +0000" MODIFIED_BY="[Empty name]" ORDER="32" O_E="0.0" SE="0.6763338940433816" STUDY_ID="STD-May-1976" TOTAL_1="46" TOTAL_2="48" VAR="0.4574275362318841" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2010-01-11 06:58:07 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>INDIVIDUAL PSYCHODYNAMIC PSYCHOTHERAPY AND MEDICATION versus MEDICATION ALONE</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.929031209236218" CI_START="0.008261274508750404" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.15555555555555556" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.46672399917455315" LOG_CI_START="-2.082952946696727" LOG_EFFECT_SIZE="-0.8081144737610868" METHOD="MH" MODIFIED="2010-01-11 06:53:51 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="0.0" P_Z="0.2140844270790877" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="44" TOTAL_2="48" WEIGHT="100.0" Z="1.2424125076096841">
<NAME>Committed suicide by three years</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.929031209236218" CI_START="0.008261274508750404" EFFECT_SIZE="0.15555555555555556" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.46672399917455315" LOG_CI_START="-2.082952946696727" LOG_EFFECT_SIZE="-0.8081144737610868" ORDER="7" O_E="0.0" SE="1.4976928591092225" STUDY_ID="STD-May-1976" TOTAL_1="44" TOTAL_2="48" VAR="2.2430839002267575" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="7.417272907127661" CI_START="0.16044746627624876" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.8702442585020426" LOG_CI_START="-0.7946671367232431" LOG_EFFECT_SIZE="0.037788560889399754" METHOD="MH" MODIFIED="2010-01-11 06:57:42 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="0.0" P_Z="0.9291051458998109" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="44" TOTAL_2="48" WEIGHT="100.0" Z="0.08897076274836893">
<NAME>Global impression: 1. Not able to be discharged (long term)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="7.417272907127661" CI_START="0.16044746627624876" EFFECT_SIZE="1.0909090909090908" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8702442585020426" LOG_CI_START="-0.7946671367232431" LOG_EFFECT_SIZE="0.037788560889399754" ORDER="8" O_E="0.0" SE="0.9779771949996554" STUDY_ID="STD-May-1976" TOTAL_1="44" TOTAL_2="48" VAR="0.9564393939393939" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.008164989931406269" CI_END="1.0169037593750079" CI_START="0.890253643888034" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9514737396623415" ESTIMABLE="YES" EVENTS_1="82" EVENTS_2="94" I2="0.0" I2_Q="0.0" ID="CMP-002.03" LOG_CI_END="0.007279852873435443" LOG_CI_START="-0.05048624004379341" LOG_EFFECT_SIZE="-0.02160319358517899" METHOD="MH" MODIFIED="2009-08-07 12:43:33 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9280008770847025" P_Q="0.0" P_Z="0.14265832989548305" Q="0.0" RANDOM="NO" SCALE="2.01" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="88" TOTAL_2="96" WEIGHT="200.0" Z="1.4659631364948749">
<NAME>Global impression: 2. Given medication during 12 months to three years follow up</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0594491199334706" CI_START="0.8493786425079646" DF="0" EFFECT_SIZE="0.9486166007905138" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="46" I2="0.0" ID="CMP-002.03.01" LOG_CI_END="0.02508010454589132" LOG_CI_START="-0.07089866347431517" LOG_EFFECT_SIZE="-0.022909279464211913" NO="1" P_CHI2="1.0" P_Z="0.34945240809094014" STUDIES="1" TAU2="0.0" TOTAL_1="44" TOTAL_2="48" WEIGHT="100.00000000000001" Z="0.9356519902852951">
<NAME>by 12 months</NAME>
<DICH_DATA CI_END="1.0594491199334706" CI_START="0.8493786425079646" EFFECT_SIZE="0.9486166007905138" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="46" LOG_CI_END="0.02508010454589132" LOG_CI_START="-0.07089866347431517" LOG_EFFECT_SIZE="-0.022909279464211913" ORDER="9" O_E="0.0" SE="0.05637840343763336" STUDY_ID="STD-May-1976" TOTAL_1="44" TOTAL_2="48" VAR="0.0031785243741765494" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0298887342430751" CI_START="0.8840385587986739" DF="0" EFFECT_SIZE="0.9541809851088202" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="48" I2="0.0" ID="CMP-002.03.02" LOG_CI_END="0.012790307506683805" LOG_CI_START="-0.05352879210424802" LOG_EFFECT_SIZE="-0.020369242298782113" MODIFIED="2009-08-07 12:43:33 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.22860261675700655" STUDIES="1" TAU2="0.0" TOTAL_1="44" TOTAL_2="48" WEIGHT="100.0" Z="1.2039663243981082">
<NAME>by three years</NAME>
<DICH_DATA CI_END="1.0298887342430751" CI_START="0.8840385587986739" EFFECT_SIZE="0.9541809851088202" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="48" LOG_CI_END="0.012790307506683805" LOG_CI_START="-0.05352879210424802" LOG_EFFECT_SIZE="-0.020369242298782113" ORDER="10" O_E="0.0" SE="0.03895616739629891" STUDY_ID="STD-May-1976" TOTAL_1="44" TOTAL_2="48" VAR="0.001517582978208462" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="3.7529609246764917" CI_START="-5.3529609246765" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.8000000000000043" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.04" MODIFIED="2010-01-11 06:57:59 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.7305568116463045" Q="0.0" RANDOM="NO" SCALE="62.510151723761815" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="44" TOTAL_2="46" UNITS="" WEIGHT="99.99999999999999" Z="0.3443849428036683">
<NAME>Global impression: 3. Achieved best level of health - MHSS - high=good (long term)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="3.7529609246764917" CI_START="-5.3529609246765" EFFECT_SIZE="-0.8000000000000043" ESTIMABLE="YES" MEAN_1="45.8" MEAN_2="46.6" ORDER="11" SD_1="11.4" SD_2="10.6" SE="2.3229819326220635" STUDY_ID="STD-May-1976" TOTAL_1="44" TOTAL_2="46" WEIGHT="99.99999999999999"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="23.231346245938788" CI_START="0.20490980282059973" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="2.1818181818181817" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-002.05" LOG_CI_END="1.3660743776969886" LOG_CI_START="-0.6884372645902266" LOG_EFFECT_SIZE="0.33881855655338095" METHOD="MH" MODIFIED="2010-01-11 06:58:07 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="1.0" P_Q="0.0" P_Z="0.5179863066843244" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="44" TOTAL_2="48" WEIGHT="100.0" Z="0.6464525724460594">
<NAME>Global impression: 4. Treatment not considered successful by treatment team (long term)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="23.231346245938795" CI_START="0.20490980282059965" EFFECT_SIZE="2.1818181818181817" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3660743776969886" LOG_CI_START="-0.6884372645902268" LOG_EFFECT_SIZE="0.33881855655338095" ORDER="12" O_E="0.0" SE="1.2068303086761594" STUDY_ID="STD-May-1976" TOTAL_1="44" TOTAL_2="48" VAR="1.456439393939394" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.577326316861588" CI_START="0.38799898695703405" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-002.06" LOG_CI_END="0.4111694083221442" LOG_CI_START="-0.4111694083221443" LOG_EFFECT_SIZE="0.0" METHOD="MH" MODIFIED="2009-02-27 13:04:24 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="1.0" P_Q="0.0" P_Z="1.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="12" TOTAL_2="12" WEIGHT="100.0" Z="0.0">
<NAME>Global impression: 5. Hospital re-admission (long term)</NAME>
<GROUP_LABEL_1>Psychodynamic therapy + m</GROUP_LABEL_1>
<GROUP_LABEL_2>Psychodynamic therapy</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.5773263168615883" CI_START="0.38799898695703405" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.4111694083221443" LOG_CI_START="-0.4111694083221443" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-01-30 14:55:22 +0000" MODIFIED_BY="[Empty name]" ORDER="31" O_E="0.0" SE="0.483045891539648" STUDY_ID="STD-Karon-1981" TOTAL_1="12" TOTAL_2="12" VAR="0.2333333333333334" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="3.4531943032937598" CI_START="0.19385572568702308" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8181818181818182" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-002.07" LOG_CI_END="0.5382210157876761" LOG_CI_START="-0.7125213672254764" LOG_EFFECT_SIZE="-0.08715017571890014" METHOD="MH" MODIFIED="2009-02-06 11:22:44 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="1.0" P_Q="0.0" P_Z="0.7847488961439988" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="44" TOTAL_2="48" WEIGHT="100.0" Z="0.27313571199831194">
<NAME>Leaving the study early (long term)</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.4531943032937598" CI_START="0.19385572568702308" EFFECT_SIZE="0.8181818181818182" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.5382210157876761" LOG_CI_START="-0.7125213672254764" LOG_EFFECT_SIZE="-0.08715017571890014" MODIFIED="2009-02-06 09:42:18 +0000" MODIFIED_BY="[Empty name]" ORDER="31" O_E="0.0" SE="0.7346922670565733" STUDY_ID="STD-May-1976" TOTAL_1="44" TOTAL_2="48" VAR="0.5397727272727272" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2010-02-16 15:05:51 +0000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>INSIGHT-ORIENTED PSYCHODYNAMIC PSYCHOTHERAPY versus REALITY-ADAPTIVE PSYCHOTHERAPY</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.289356119494668" CI_START="0.9949683324896551" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1326378539493294" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="61" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.11037288583351065" LOG_CI_START="-0.002190741609912091" LOG_EFFECT_SIZE="0.054091072111799275" METHOD="MH" MODIFIED="2009-02-05 14:30:19 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="0.0" P_Z="0.05960917187802176" Q="0.0" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="88" TOTAL_2="76" WEIGHT="100.0" Z="1.8836733611409617">
<NAME>Global impression: 1. Not able to perform major household responsibilities (long term)</NAME>
<GROUP_LABEL_1>*Prone to bias</GROUP_LABEL_1>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.289356119494668" CI_START="0.9949683324896551" EFFECT_SIZE="1.1326378539493294" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="61" LOG_CI_END="0.11037288583351065" LOG_CI_START="-0.002190741609912091" LOG_EFFECT_SIZE="0.054091072111799275" ORDER="14" O_E="0.0" SE="0.06612043195920875" STUDY_ID="STD-Gunderson-1984" TOTAL_1="88" TOTAL_2="76" VAR="0.004371911522472353" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.2143325207569549" CI_START="0.9597193260568266" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0795454545454546" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="64" I2="0.0" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="0.08433762591213374" LOG_CI_START="-0.017855759634775436" LOG_EFFECT_SIZE="0.03324093313867916" METHOD="MH" MODIFIED="2009-08-07 12:44:13 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="0.0" P_Z="0.20229022939538033" Q="0.0" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="88" TOTAL_2="76" WEIGHT="100.0" Z="1.275053789746681">
<NAME>Global impression: 2. Not able to enjoy a significant relationship (long term)</NAME>
<GROUP_LABEL_1>*Prone to bias</GROUP_LABEL_1>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2143325207569549" CI_START="0.9597193260568266" EFFECT_SIZE="1.0795454545454546" ESTIMABLE="YES" EVENTS_1="80" EVENTS_2="64" LOG_CI_END="0.08433762591213374" LOG_CI_START="-0.017855759634775436" LOG_EFFECT_SIZE="0.03324093313867916" ORDER="15" O_E="0.0" SE="0.06002890053567142" STUDY_ID="STD-Gunderson-1984" TOTAL_1="88" TOTAL_2="76" VAR="0.003603468899521532" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.2315779491139027" CI_START="0.9019052301324072" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0539291217257318" ESTIMABLE="YES" EVENTS_1="72" EVENTS_2="59" I2="0.0" I2_Q="0.0" ID="CMP-003.03" LOG_CI_END="0.09046190444041274" LOG_CI_START="-0.04483909460091879" LOG_EFFECT_SIZE="0.02281140491974697" METHOD="MH" MODIFIED="2009-02-05 14:30:41 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="0.0" P_Z="0.5086829258236834" Q="0.0" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="88" TOTAL_2="76" WEIGHT="100.0" Z="0.6608899031973309">
<NAME>Global impression: 3. Not self supporting (long term)</NAME>
<GROUP_LABEL_1>*Prone to Bias</GROUP_LABEL_1>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2315779491139027" CI_START="0.9019052301324072" EFFECT_SIZE="1.0539291217257318" ESTIMABLE="YES" EVENTS_1="72" EVENTS_2="59" LOG_CI_END="0.09046190444041274" LOG_CI_START="-0.04483909460091879" LOG_EFFECT_SIZE="0.02281140491974697" ORDER="16" O_E="0.0" SE="0.07947647658762498" STUDY_ID="STD-Gunderson-1984" TOTAL_1="88" TOTAL_2="76" VAR="0.006316510330783301" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.555047543323072" CI_START="0.9270436141928032" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2006651884700665" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="41" I2="0.0" I2_Q="0.0" ID="CMP-003.04" LOG_CI_END="0.19174367148968585" LOG_CI_START="-0.0328998333229286" LOG_EFFECT_SIZE="0.07942191908337863" METHOD="MH" MODIFIED="2010-02-16 15:05:51 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Q="0.0" P_Z="0.1657845527705308" Q="0.0" RANDOM="NO" SCALE="2.0595090774751585" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="88" TOTAL_2="76" WEIGHT="100.00000000000001" Z="1.3858767126725804">
<NAME>Global impression: 4. Hospital re-admission (long term)</NAME>
<GROUP_LABEL_1>*prone to bias</GROUP_LABEL_1>
<GROUP_LABEL_2/>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.555047543323072" CI_START="0.9270436141928032" EFFECT_SIZE="1.2006651884700665" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="41" LOG_CI_END="0.19174367148968585" LOG_CI_START="-0.0328998333229286" LOG_EFFECT_SIZE="0.07942191908337863" ORDER="13" O_E="0.0" SE="0.1319567067302127" STUDY_ID="STD-Gunderson-1984" TOTAL_1="88" TOTAL_2="76" VAR="0.017412572451083363" WEIGHT="100.00000000000001"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.0261430656475101" CI_END="0.5805665473057033" CI_START="0.418317513412829" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4928094504365692" ESTIMABLE="YES" EVENTS_1="101" EVENTS_2="177" I2="0.0" I2_Q="0.0" ID="CMP-003.05" LOG_CI_END="-0.2361479921679626" LOG_CI_START="-0.3784939527291198" LOG_EFFECT_SIZE="-0.30732097244854123" METHOD="MH" MODIFIED="2009-02-06 11:23:14 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.5986540422468526" P_Q="0.0" P_Z="2.6055099168694187E-17" Q="0.0" RANDOM="NO" SCALE="2.234705478185555" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="264" TOTAL_2="228" WEIGHT="300.0" Z="8.463015533681833">
<NAME>Leaving the study early:</NAME>
<GROUP_LABEL_1>Control</GROUP_LABEL_1>
<GROUP_LABEL_2>Treatment</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.6795451637243891" CI_START="0.31220580234028616" DF="0" EFFECT_SIZE="0.46060606060606063" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="45" I2="0.0" ID="CMP-003.05.01" LOG_CI_END="-0.16778167402424882" LOG_CI_START="-0.5055590298419809" LOG_EFFECT_SIZE="-0.3366703519331149" NO="1" P_CHI2="1.0" P_Z="9.341779836788751E-5" STUDIES="1" TAU2="0.0" TOTAL_1="88" TOTAL_2="76" WEIGHT="100.0" Z="3.907081117701673">
<NAME>at six months</NAME>
<DICH_DATA CI_END="0.679545163724389" CI_START="0.31220580234028616" EFFECT_SIZE="0.46060606060606063" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="45" LOG_CI_END="-0.1677816740242489" LOG_CI_START="-0.5055590298419809" LOG_EFFECT_SIZE="-0.3366703519331149" ORDER="17" O_E="0.0" SE="0.19841209083221317" STUDY_ID="STD-Gunderson-1984" TOTAL_1="88" TOTAL_2="76" VAR="0.03936735778841041" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.6216199036758837" CI_START="0.341298503816336" DF="0" EFFECT_SIZE="0.46060606060606063" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="60" I2="0.0" ID="CMP-003.05.02" LOG_CI_END="-0.20647508828980432" LOG_CI_START="-0.4668656155764255" LOG_EFFECT_SIZE="-0.3366703519331149" NO="2" P_CHI2="1.0" P_Z="4.014960236259435E-7" STUDIES="1" TAU2="0.0" TOTAL_1="88" TOTAL_2="76" WEIGHT="100.0" Z="5.068247077398455">
<NAME>at 12 months</NAME>
<DICH_DATA CI_END="0.6216199036758837" CI_START="0.341298503816336" EFFECT_SIZE="0.46060606060606063" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="60" LOG_CI_END="-0.20647508828980432" LOG_CI_START="-0.4668656155764255" LOG_EFFECT_SIZE="-0.3366703519331149" ORDER="18" O_E="0.0" SE="0.1529546846820593" STUDY_ID="STD-Gunderson-1984" TOTAL_1="88" TOTAL_2="76" VAR="0.02339513556618819" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.6665718429700336" CI_START="0.43709406597382505" DF="0" EFFECT_SIZE="0.5397727272727273" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="72" I2="0.0" ID="CMP-003.05.03" LOG_CI_END="-0.176153035561495" LOG_CI_START="-0.3594250894891091" LOG_EFFECT_SIZE="-0.26778906252530205" NO="3" P_CHI2="1.0" P_Z="1.018456095786571E-8" STUDIES="1" TAU2="0.0" TOTAL_1="88" TOTAL_2="76" WEIGHT="100.00000000000001" Z="5.727626299322604">
<NAME>at 24 months</NAME>
<DICH_DATA CI_END="0.6665718429700336" CI_START="0.43709406597382505" EFFECT_SIZE="0.5397727272727273" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="72" LOG_CI_END="-0.176153035561495" LOG_CI_START="-0.3594250894891091" LOG_EFFECT_SIZE="-0.26778906252530205" ORDER="19" O_E="0.0" SE="0.1076549116883788" STUDY_ID="STD-Gunderson-1984" TOTAL_1="88" TOTAL_2="76" VAR="0.01158958001063264" WEIGHT="100.00000000000001"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2009-02-02 17:04:21 +0000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>INDIVIDUAL PSYCHODYNAMIC PSYCHOTHERAPY versus GROUP PSYCHOTHERAPY</NAME>
<DICH_OUTCOME CHI2="0.038870430540949685" CI_END="1.6326029781316085" CI_START="0.770007550881513" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.121212121212121" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="33" I2="0.0" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="0.212880584387427" LOG_CI_START="-0.11350501600921202" LOG_EFFECT_SIZE="0.04968778418910748" METHOD="MH" MODIFIED="2009-02-02 13:09:07 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8437056630263321" P_Q="0.0" P_Z="0.5506703635930199" Q="0.0" RANDOM="NO" SCALE="2.445298530680992" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="100" TOTAL_2="100" WEIGHT="200.0" Z="0.5967559069021493">
<NAME>Global impression: 1. Returned to hospital (long term)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.9795245990956787" CI_START="0.5799166043189866" DF="0" EFFECT_SIZE="1.0714285714285714" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="14" I2="0.0" ID="CMP-004.01.01" LOG_CI_END="0.296560902999127" LOG_CI_START="-0.23663445624424062" LOG_EFFECT_SIZE="0.029963223377443202" NO="1" P_CHI2="1.0" P_Z="0.8256510454068478" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="0.22028263248147456">
<NAME>at 12 months</NAME>
<DICH_DATA CI_END="1.9795245990956787" CI_START="0.5799166043189866" EFFECT_SIZE="1.0714285714285714" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="14" LOG_CI_END="0.296560902999127" LOG_CI_START="-0.23663445624424062" LOG_EFFECT_SIZE="0.029963223377443202" ORDER="20" O_E="0.0" SE="0.3132015933791495" STUDY_ID="STD-O_x0027_Brien-1972" TOTAL_1="50" TOTAL_2="50" VAR="0.0980952380952381" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.8570247893882195" CI_START="0.7219721725138288" DF="0" EFFECT_SIZE="1.1578947368421053" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="19" I2="0.0" ID="CMP-004.01.02" LOG_CI_END="0.2688177011671667" LOG_CI_START="-0.14147954142841213" LOG_EFFECT_SIZE="0.0636690798693773" NO="2" P_CHI2="1.0" P_Z="0.5429975842473258" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="0.6082863374043468">
<NAME>at 24 months</NAME>
<DICH_DATA CI_END="1.8570247893882195" CI_START="0.7219721725138288" EFFECT_SIZE="1.1578947368421053" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="19" LOG_CI_END="0.2688177011671667" LOG_CI_START="-0.14147954142841213" LOG_EFFECT_SIZE="0.0636690798693773" ORDER="21" O_E="0.0" SE="0.24101063130474942" STUDY_ID="STD-O_x0027_Brien-1972" TOTAL_1="50" TOTAL_2="50" VAR="0.058086124401913866" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.6671696596971306" CI_START="0.9623762255461863" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2666666666666666" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="30" I2="0.0" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="0.22197979810094834" LOG_CI_START="-0.016655114306652903" LOG_EFFECT_SIZE="0.10266234189714771" METHOD="MH" MODIFIED="2009-02-02 12:25:01 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="0.0" P_Z="0.09172275872608654" Q="0.0" RANDOM="NO" SCALE="2.278558177015458" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="1.6863793370121962">
<NAME>Global impression: 2. Not improved at 24 months</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.6671696596971306" CI_START="0.9623762255461863" EFFECT_SIZE="1.2666666666666666" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="30" LOG_CI_END="0.22197979810094834" LOG_CI_START="-0.016655114306652903" LOG_EFFECT_SIZE="0.10266234189714771" ORDER="22" O_E="0.0" SE="0.14017532881009248" STUDY_ID="STD-O_x0027_Brien-1972" TOTAL_1="50" TOTAL_2="50" VAR="0.019649122807017545" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.07903469405635247" CI_END="1.0892742184257094" CI_START="0.3586103419986906" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.625" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="24" I2="0.0" I2_Q="0.0" ID="CMP-004.03" LOG_CI_END="0.03713722462038705" LOG_CI_START="-0.44537718993223663" LOG_EFFECT_SIZE="-0.2041199826559248" METHOD="MH" MODIFIED="2009-02-02 13:09:18 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.7786098591060011" P_Q="0.0" P_Z="0.09726446540362532" Q="0.0" RANDOM="NO" SCALE="5.996439150006279" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="100" TOTAL_2="100" WEIGHT="200.0" Z="1.6582626444496453">
<NAME>Global impression: 3. Discharged from therapy (long term)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="3.180472848141597" CI_START="0.17686049429055115" DF="0" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" I2="0.0" ID="CMP-004.03.01" LOG_CI_END="0.502491692334305" LOG_CI_START="-0.752369165550905" LOG_EFFECT_SIZE="-0.12493873660829993" NO="1" P_CHI2="1.0" P_Z="0.6963273006688617" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="0.3902829903211535">
<NAME>at 12 months</NAME>
<DICH_DATA CI_END="3.180472848141597" CI_START="0.17686049429055115" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.502491692334305" LOG_CI_START="-0.752369165550905" LOG_EFFECT_SIZE="-0.12493873660829993" ORDER="23" O_E="0.0" SE="0.7371114795831993" STUDY_ID="STD-O_x0027_Brien-1972" TOTAL_1="50" TOTAL_2="50" VAR="0.5433333333333332" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.0919370882132886" CI_START="0.3296893235754632" DF="0" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="20" I2="0.0" ID="CMP-004.03.02" LOG_CI_END="0.0381976172799971" LOG_CI_START="-0.4818951165127098" LOG_EFFECT_SIZE="-0.22184874961635637" NO="2" P_CHI2="1.0" P_Z="0.09451064798545791" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="1.6720693484504896">
<NAME>at 24 months</NAME>
<DICH_DATA CI_END="1.0919370882132886" CI_START="0.3296893235754632" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="20" LOG_CI_END="0.0381976172799971" LOG_CI_START="-0.4818951165127098" LOG_EFFECT_SIZE="-0.22184874961635637" ORDER="24" O_E="0.0" SE="0.30550504633038933" STUDY_ID="STD-O_x0027_Brien-1972" TOTAL_1="50" TOTAL_2="50" VAR="0.09333333333333332" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.13373404574879227" CI_END="0.9461566006219922" CI_START="0.44654341545813186" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.65" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="40" I2="0.0" I2_Q="0.0" ID="CMP-004.04" LOG_CI_END="-0.02403697653967648" LOG_CI_START="-0.35013631017461233" LOG_EFFECT_SIZE="-0.1870866433571444" METHOD="MH" MODIFIED="2009-02-02 17:04:21 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.7145915336158488" P_Q="0.0" P_Z="0.024518590782358414" Q="0.0" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="100" TOTAL_2="100" WEIGHT="200.0" Z="2.248904215051172">
<NAME>Global impression: 4. Remaining in therapy (long term)</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.001927282314587" CI_START="0.45801425952787683" DF="0" EFFECT_SIZE="0.6774193548387096" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="31" I2="0.0" ID="CMP-004.04.01" LOG_CI_END="8.362025337022075E-4" LOG_CI_START="-0.3391210007344091" LOG_EFFECT_SIZE="-0.16914239910035345" NO="1" P_CHI2="1.0" P_Z="0.051137749159059546" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="1.9503220247046285">
<NAME>at 12 months</NAME>
<DICH_DATA CI_END="1.001927282314587" CI_START="0.4580142595278769" EFFECT_SIZE="0.6774193548387096" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="31" LOG_CI_END="8.362025337022075E-4" LOG_CI_START="-0.33912100073440904" LOG_EFFECT_SIZE="-0.16914239910035345" ORDER="25" O_E="0.0" SE="0.1996925440149848" STUDY_ID="STD-O_x0027_Brien-1972" TOTAL_1="50" TOTAL_2="50" VAR="0.03987711213517664" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.5414659410724874" CI_START="0.20022626973768998" DF="0" EFFECT_SIZE="0.5555555555555556" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="9" I2="0.0" ID="CMP-004.04.02" LOG_CI_END="0.18793393336503209" LOG_CI_START="-0.6984789435716443" LOG_EFFECT_SIZE="-0.255272505103306" NO="2" P_CHI2="1.0" P_Z="0.2589503507858454" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="1.1288755596034497">
<NAME>at 24 months</NAME>
<DICH_DATA CI_END="1.5414659410724874" CI_START="0.20022626973768998" EFFECT_SIZE="0.5555555555555556" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="9" LOG_CI_END="0.18793393336503209" LOG_CI_START="-0.6984789435716443" LOG_EFFECT_SIZE="-0.255272505103306" ORDER="26" O_E="0.0" SE="0.5206833117271102" STUDY_ID="STD-O_x0027_Brien-1972" TOTAL_1="50" TOTAL_2="50" VAR="0.2711111111111111" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2009-02-27 13:05:31 +0000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>INDIVIDUAL PSYCHODYNAMIC THERAPY AND MEDICATION versus INDIVIDUAL PSYCHODYNAMIC THERAPY</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.577326316861588" CI_START="0.38799898695703405" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" I2="0.0" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="0.4111694083221442" LOG_CI_START="-0.4111694083221443" LOG_EFFECT_SIZE="0.0" METHOD="MH" MODIFIED="2009-02-27 13:05:31 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="0.0" P_Z="1.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="12" TOTAL_2="12" WEIGHT="100.0" Z="0.0">
<NAME>Global impression: 1. Hospital re-admission (long term)</NAME>
<GROUP_LABEL_1>Psychodynamic therapy + m</GROUP_LABEL_1>
<GROUP_LABEL_2>Psychodynamic therapy</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.5773263168615883" CI_START="0.38799898695703405" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.4111694083221443" LOG_CI_START="-0.4111694083221443" LOG_EFFECT_SIZE="0.0" MODIFIED="2009-01-30 14:56:48 +0000" MODIFIED_BY="[Empty name]" ORDER="29" O_E="0.0" SE="0.483045891539648" STUDY_ID="STD-Karon-1981" TOTAL_1="12" TOTAL_2="12" VAR="0.2333333333333334" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2009-08-10 10:49:23 +0100" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2009-08-10 10:49:23 +0100" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Methodological quality summary: review authors' judgements about each methodological quality item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAASoAAAFiCAIAAADOUwJ5AAAOpUlEQVR42u3dsa4cRRbG8SuREDhw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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2010-02-03 18:32:00 +0000" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2010-02-03 18:32:00 +0000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2009-07-24 16:29:49 +0100" MODIFIED_BY="[Empty name]">Details of past searches for earlier versions of this review</TITLE>
<APPENDIX_BODY MODIFIED="2010-02-03 18:32:00 +0000" MODIFIED_BY="[Empty name]">
<P>1. December 2006<BR/>We searched The Cochrane Schizophrenia Group Trials Register (December 2006) using the phrase:</P>
<P>(psychoanaly* or psychodynamic* or insight?orient* or * EIO* or analytic* or dynamic*) in title, abstract and index fields in REFERENCE) OR (psychoanalys* or psychodynam* .. in interventions field in STUDY)]</P>
<P>2. The following search phrase was constructed to assist identification for previous versions of this review (<LINK REF="REF-Malmberg-2001" TYPE="REFERENCE">Malmberg 2001</LINK>)</P>
<P>[and (psychoanaly* or ((analytic* or dynamic* or psychodynamic*) and (therap* or psychotherap*)))]</P>
<P>1. We searched Biological Abstracts (January 1985 to January 1999) using the Cochrane Schizophrenia Group's terms for both randomised controlled trials and schizophrenia combined with the phrase:</P>
<P>[and (psychoanaly* or ((analytic* or dynamic* or psychodynamic*) near2 (therap* or psychotherap*)))]</P>
<P>2. We searched CINAHL (January 1982 to January 1999) using the Cochrane Schizophrenia Group's terms for both randomised controlled trials and schizophrenia combined with the phrase:</P>
<P>[and (psychoanaly* or ((analytic* or dynamic* or psychodynamic*) near2 (therap* or psychotherap* or "PSYCHOANALYSIS"/ all topical subheadings / all age subheadings or explode "PSYCHOANALYTIC-THEORY"/ all topical subheadings / all age subheadings)))]</P>
<P>3. We searched The Cochrane Library CENTRAL (Issue 1, 1999) using the Cochrane Schizophrenia Group's terms for randomised controlled trials and for schizophrenia combined with the phrase:</P>
<P>[and (psychoanaly* or explode psychoanalysis(MeSH) or explode psychoanalytic-therapy(MeSH) or ((analytic* or dynamic* or psychodynamic* or insight-oriented) and (therap* or psychotherap*)))]</P>
<P>4. We searched Dissertation Abstracts (1866 to December 1999) using the Cochrane Schizophrenia Group's terms for both randomised controlled trials and schizophrenia combined with the phrase:</P>
<P>[and ((psychoanaly? or psychotherap?) or ((analytic or dynamic or psychodynamic) and therap?))]</P>
<P>5. We searched EMBASE (January 1980 to January 1999) using the Cochrane Schizophrenia Group's terms for both randomised controlled trials and schizophrenia combined with the phrase:</P>
<P>[and (psychoanaly* or ((analytic* or dynamic* or psychodynamic*) near2 (therap* or psychotherap* or "PSYCHOANALYTIC-THEORY"/ all subheadings or "PSYCHOANALYSIS"/ all subheadings)))]</P>
<P>6. We searched MEDLINE (January 1966 to January 1999) using the Cochrane Schizophrenia Group's terms for both randomised controlled trials and schizophrenia combined with the phrase:</P>
<P>[and (exp psychoanalysis/all subheadings or exp psychoanalytic therapy/all subheadings or (psychoanaly* or ((analytic* or dynamic* or psychodynamic*) near2 (therap* or psychotherap*))))]</P>
<P>7. We searched National Research Register (August 2000) using the term:</P>
<P>[randomi* [and (psychoanaly* or explode psychoanalysis(MeSH) or explode psychoanalytic-therapy(MeSH) or ((analytic* or dynamic* or psychodynamic* or insight-oriented) and (therap* or psychotherap*)))]</P>
<P>8. We searched PsycLIT (January 1974 to January 1999) using the Cochrane Schizophrenia Group's terms for both randomised controlled trials and schizophrenia combined with the phrase:</P>
<P>[and (psychoanaly* or ((analytic* or dynamic* or psychodynamic*) near2 (therap* or psychotherap*or explode "PSYCHOANALYSIS" or explode "PSYCHOANALYSTS" or "PSYCHODYNAMICS-" IN DE")))]</P>
<P>9. We searched Sociofile (January 1974-October 1998) using the Cochrane Schizophrenia Group's terms for both randomised controlled trials and schizophrenia combined with the phrase:</P>
<P>[and ((psychoanaly* or psychotherap*) or ((analytic or dynamic or psychodynamic) and therap*))]<BR/>
</P>
<P>10. Searching other resources<BR/>10.1 Unjpublished studies<BR/>We appealed to practitioners on the Psych-couns mailbase list (<A HREF="http://www.mailbase.ac.uk/lists/psych-couns/">http://www.mailbase.ac.uk/lists/psych-couns/</A>) in June 1999 for unpublished studies.</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2009-07-24 12:01:58 +0100" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2009-07-24 12:01:54 +0100" MODIFIED_BY="[Empty name]">Risk of bias assessed in earlier versions of this review</TITLE>
<APPENDIX_BODY MODIFIED="2009-07-24 12:01:58 +0100" MODIFIED_BY="[Empty name]">
<P>We assessed the methodological quality of included studies using the criteria described in the Cochrane Handbook (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>) which is based on the degree of allocation concealment. Poor concealment has been associated with overestimation of treatment effect (<LINK REF="REF-Schulz-1995" TYPE="REFERENCE">Schulz 1995</LINK>). Category A includes studies in which allocation has been randomised and concealment is explicit. Category B studies are those which have randomised allocation but in which concealment is not explicit. Category C studies are those in which allocation has neither been randomised nor concealed. Only trials that are stated to be randomised (categories A or B of the handbook) will be included in this review. The categories are defined below:</P>
<P>A. Low risk of bias (adequate allocation concealment)<BR/>B. Moderate risk of bias (some doubt about the results)<BR/>C. High risk of bias (inadequate allocation concealment).</P>
<P>When disputes arose as to which category a trial should be allocated, again resolution was attempted by discussion. When this was not possible we did not enter the data and the trial was added to the list of those awaiting assessment until further information could be obtained.</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>